tag:blogger.com,1999:blog-33727507962460853842024-03-12T23:47:39.036-04:00Market Research Blog by BCC ResearchMarket Research Blog by BCC Research providing high-quality market research blogs on different topics such as biotech, chemicals, energy, healthcare, information technology, nanotech, pharma and plastics.
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.comBlogger534125tag:blogger.com,1999:blog-3372750796246085384.post-6702071360988491952015-05-15T03:41:00.002-04:002015-05-15T03:41:18.977-04:00The 26th Flame Retardant Conference: A Quarter Century of Insights and Knowledge<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">The flame retardant industry expanded in the
1970s when synthetic materials became popular in the manufacture of products.
The growing demand and consumption of these flammable products led many world governments
to insist their manufacturers make them safer from f<a href="https://www.blogger.com/null" name="_GoBack"></a>ire. In many countries, the use of flame retardant
chemicals in flammable products is mandated. In recent decades, their worldwide
use has increased as highly populated countries such as China and India have
recognized the safety and protective value of flame retardant chemicals.<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">Presently, the flame retardant chemicals
industry is in transition. Because many organizations and governments have
reassessed the safety benefits of flame retardant chemicals against its harmful
effects on human health and the environment, the use of some widely used flame
retardant chemicals is being discontinued. However, emerging technology promises
flame retardant protection with reduced or eliminated toxic effects.<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">The
global consumption of flame retardant chemicals in 2013 and 2014 reached about $3.9
billion pounds and $4.2 billion pounds, respectively. In 2019, total consumption
is projected to reach $5.7 billion, reflecting a five-year compound annual
growth rate (CAGR) of 6.7%. <o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">For 25 years, BCC Research has convened
the <a href="http://www.bccresearch.com/conference/flame">Annual
Conference on Recent Advances in Flame Retardancy of Polymeric Materials</a><span class="MsoHyperlink">.</span> A signature staple of the industry, this
cutting-edge conference focuses on the development of flame retardant chemicals
and materials such as plastics, textiles, and surface coatings that inhibit,
suppress, or delay the production of flames to prevent the spread of fire. <o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">Come join this year’s conference to
hear BCC Research's renowned analyst Marcanne Green, one of more than 40 expert
speakers, share her insights. <i>For the
complete conference brochure and list of speakers</i>, <a href="http://www.bccresearch.com/conference/flame-conference-brochure">click
here</a>. <o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<i><span style="font-family: inherit;">Find
detailed information about the Conference by visiting the following link:<o:p></o:p></span></i></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: left;">
<br /></div>
<div style="text-align: left;">
</div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: left;">
<a href="http://www.bccresearch.com/conference/flame"><span style="font-family: inherit;">26th Annual
Conference: Recent Advances in Flame Retardancy of Polymeric Materials</span></a><span style="font-size: 12.0pt; mso-ascii-font-family: Calibri; mso-ascii-theme-font: minor-latin; mso-bidi-font-weight: bold; mso-hansi-font-family: Calibri; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-68447394342405139382015-05-11T03:35:00.000-04:002015-05-11T03:35:01.651-04:002015 Flame Conference Promises to Provide the Latest Breakthroughs in Flame Retardancy<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">On May 17<sup>th</sup>, the <a href="http://www.bccresearch.com/conference/flame">26th
Annual Conference on Recent Advances in Flame Retardancy of Polymeric Materials</a> will welcome scientific and
technical specialists to the premier fire retardant event in the industry.
Scheduled at the Sheraton Stamford Hotel (Connecticut) May 17-20, the
conference not only provides participants cutting-edge information about recent
innovations in the industry, but also terrific networking opportunities with
world-class experts and fellow professionals. <o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">The
conference kicks off on Sunday, May 17<sup>th</sup>, with a one-day Short
Course that will acquaint industry newcomers with the evaluation and commercial
applications of flame retardants. The main conference from May 18-20 will
feature experts from around the globe who will share their latest research on
topics such as foams and fabrics, nanocomposites, and new technology. Evening
receptions on Sunday, Monday and Tuesday will offer attendees additional
networking opportunities during this vibrant four-day learning experience.<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">Prominent
speakers at this year’s highly anticipated event include Charles Wilkie,
(conference chairman, Marquette University), Dr. Matthew S. Blais (Fire
Technology Department, Southwest Texas Research Institute) and Marshall Moore
(Great Lakes Solutions). Overall, more than <a href="http://www.bccresearch.com/conference/flame-conference-brochure">40 informative sessions</a> will offer a breadth of topics and
industries that strike a balance between academia and industry, including “Material
Selection Influence on the Flammability of Upholstered Furniture,”
“Reformulating Targeted Materials: How This Impacts Aerospace OEMs”, and
“Comparative Burn of Flat Panel Televisions from United States, Mexican and
Brazilian Markets.”<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><em>Professor Jaime C.
Grunlan appreciated last year’s conference so much, he’s back this year. “</em>Flame 2014 was the most technically strong topical conference I
attended last year,” he says. “The networking was great and everything was very
well-organized. If you want to know about the latest breakthroughs in flame
retardant research, Flame 2015 is the conference to attend.”<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;">We hope to see
you there!<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: left;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<i><span style="font-family: inherit;">Find
detailed information about the Conference by visiting the following link:<o:p></o:p></span></i></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: left;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><a href="http://www.bccresearch.com/conference/flame">26th Annual
Conference: Recent Advances in Flame Retardancy of Polymeric Materials</a><o:p></o:p></span></div>
<div style="text-align: left;">
</div>
<div class="MsoNormal" style="text-align: left;">
<br /></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-51997683132001317252015-05-04T05:40:00.001-04:002015-05-04T05:40:39.007-04:00Flame Retardant Flooring at the London Underground Station<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">After a successful trial at a London Underground
station, a </span><span lang="EN-IN"><a href="http://www.rubbernews.com/article/20150420/NEWS/304209973/tarrc-flame-retardant-nr-passes-test-in-flooring-use">flame retardant natural rubber</a></span><span lang="EN-IN"> has been approved for commercial
use in flooring.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Natural-FR, developed by the Tun Abdul Razak
Research Center (TARRC), is a zero halogen, low smoke, low toxic modified NR
compound that will help the matting maker meet sustainability targets in
products. Because it’s derived from renewable resources, the product will “have
a significant negative carbon footprint,” according to TARRC.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Before Natural-FR was certified for use, the
industry used synthetic materials. But TARRC, the research and promotion center
of the Malaysian Rubber Board, took on the challenge of developing a usable
compound based on natural rubber, according to Marina Fernando, head of TARRC's
industrial support unit.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">“What we had to do was look at the various
standards currently in place in Europe, do the various testing and achieve
third-party certification,” she said. “You just can't go in and put the
material anywhere. You have to go to a certified laboratory that would do all
the tests.”<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">TARRC modified the natural rubber and then added
fire retardant additives in order to meet criteria for smoke density, smoke
toxicity, heat release rate, flame spread, and dry and wet slip resistance.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">“What's proprietary is the modified natural rubber
and the way we have optimized the additives package that goes into the rubber
compound to give it the flame retardancy,” Fernando said.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">TARRC also is looking to develop the compound for
use in other applications.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<i><span style="font-family: inherit;">For BCC Research flame
retardant chemicals report, visit the following link:<o:p></o:p></span></i></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div style="text-align: left;">
</div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/chemicals/flame-retardant-chemicals-report-chm014m.html"><span lang="EN-US"><span style="font-family: inherit;">Flame Retardant Chemicals: Technologies and Global Markets</span></span></a></span><span style="font-family: inherit;"> (<span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">CHM014M)</span></span><span style="font-size: 12pt;"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-78689902139234124482015-04-28T06:06:00.001-04:002015-04-28T06:06:14.792-04:00Biomarker Discovery Improves Treatment Options for Ovarian Cancer Patients<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN">A </span><span lang="EN-IN"><a href="http://www.business-standard.com/article/news-ians/cancer-treatment-breakthrough-by-indian-american-professor-115032500452_1.html">biomarker</a></span><span lang="EN-IN"> that
can help predict the success of chemotherapy in ovarian cancer patients has
been discovered by researchers.<o:p></o:p></span></span></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<span lang="EN-IN"><span style="font-family: inherit;">The
discovery, by cancer researcher Madhuri Koti of Queen’s University, could lead
to better treatment options in the fight against ovarian cancer.<o:p></o:p></span></span></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<span lang="EN-IN"><span style="font-family: inherit;">Biomarkers
are an indicator of a biological state or condition.<o:p></o:p></span></span></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<span lang="EN-IN"><span style="font-family: inherit;">"Rece<a href="https://www.blogger.com/null" name="_GoBack"></a>nt successes in harnessing the immune system to combat
cancer are evidence for the significant roles of a cancer patient's immune
responses in fighting cancer," Koti explains. "Many of these
successes are based on boosting anti-cancer immunity via different therapies.
Such therapies would prove to be most effective when coupled with markers
predicting a patient's eventual response to a specific therapy".<o:p></o:p></span></span></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-family: inherit;">Koti conducted the study in retrospective cohorts of more
than 200 ovarian cancer patients. The study utilized a combination of
cutting-edge and more established detection technologies for identifying such
markers.<o:p></o:p></span></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<span lang="EN-IN"><span style="font-family: inherit;">A
major impact of this discovery is that these novel markers, when used at the
time of treatment initiation in the specific type of ovarian cancer patient,
will help oncologists make decisions on additional treatment needed in these
patients, thus increasing their potential for survival.<o:p></o:p></span></span></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<span lang="EN-IN"><span style="font-family: inherit;">Ovarian
cancer is responsible for approximately 152,000 deaths worldwide each year. It
has the highest mortality rate of all gynaecological cancers.<o:p></o:p></span></span></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left; vertical-align: baseline;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For our BCC
Research reports on cancer or biomarkers, visit the following links:<o:p></o:p></span></span></i></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left; vertical-align: baseline;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/biotechnology/biological-therapies-cancer-technologies-markets-report-bio048c.html">Biological Therapies for Cancer: Technologies and Global Markets</a></span><b><span lang="EN-IN" style="color: #1473b0;"> </span></b><span lang="EN-IN">(</span><span lang="EN-IN">BIO048C)<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/radiotherapy-technologies-markets-report-hlc176a.html">Radiotherapy: Technologies and Global Markets</a></span><span lang="EN-IN"> (</span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">HLC176A)<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/membrane-and-separation-technology/chromatography-reagents-global-markets-mst034e.html">Global Markets for Reagents for Chromatography</a></span><span lang="EN-IN"> (</span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">MST034E)<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/pharmaceuticals/therapeutics-silent-cancers-report-phm169a.html">Therapeutics for 'Silent' Cancers</a></span><span lang="EN-IN"> (</span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">PHM169A)<o:p></o:p></span></span></div>
<div style="text-align: left;">
</div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/biotechnology/3d-cell-culture-technologies-global-markets-report-bio140a.html">3D Cell Cultures: Technologies and Global Markets</a></span><span lang="EN-IN"> (</span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">BIO140A)</span></span><span lang="EN-IN" style="font-size: 12.0pt; mso-bidi-font-family: Arial; mso-bidi-font-weight: bold; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN; mso-font-kerning: 18.0pt;"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-8786412195953045932015-04-24T03:45:00.002-04:002015-04-24T03:45:17.283-04:00A “One-Pot Process” for Flame Retardants<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">National
Institute of Standards and Technology (NIST) researchers took a trip to the
grocery store and cooked up their best </span><span lang="EN-IN"><a href="http://phys.org/news/2015-04-bio-flame-retardants.html"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">fire-resistant
coatings</span></a></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"> for furniture padding yet. More important,
these protective coatings were formulated in a single step, a process far
simpler than the time-consuming “layer by layer” process deposition process required
of previous “green” flame retardant candidates.</span><span lang="EN-IN"><o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">To formulate the fire protective
coating, the NIST team prepared nine water-based mixtures composed of various
combinations of potato starch, seaweed gel (agar), laundry booster, clay and
similar everyday compounds. In laboratory tests, six of these
"bioinspired" coatings reduced the peak heat release rate—a key
measure of flammability—of polyurethane foam by at least 63 percent, compared
with untreated foam.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">Encouraged by the lab results, the team
subjected the top-performing mixture—starch and a boron-containing compound
used in deodorant and other products—to a full-scale fire test in which chairs
padded with treated or untreated </span><span lang="EN-IN"><a href="http://phys.org/tags/polyurethane+foam/"><span style="color: #313d57; text-decoration: none;">polyurethane foam</span></a></span><span lang="EN-IN" style="color: #313d57;"> were ignited</span><span lang="EN-IN">.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">The upholstered fabric of both chairs
was completely engulfed in flames 90 seconds after ignition. In less than two
minutes, the upholstery fabric on both chairs was completely consumed. Within
six minutes, the untreated padding had burned completely, leaving a burning,
melted pool. However, the flames on </span><span lang="EN-IN">the chair treated with the
NIST-devised coating remained confined to the padding 90 seconds after ignition,
although the fabric had burned completely. Combustion could not be sustained
and the flames did not spread because the coating produced a 71% drop in the
total amount of heat released, the study reported. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN" style="line-height: 115%;"><span style="font-family: inherit;">Furniture
fires are the leading cause of death in house fires. According to the National
Fire Protection Association, they accounted for about 30% of more than 2,700
deaths in residential fires in 2013.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">"The results of the
full-scale fire tests are very encouraging," says NIST team leader Rick
Davis. "The performance of our coating suggests that fire can be contained
to burning furniture so that it does not spread, intensify to the point of
flashover, and increase the risk of injury or death." <o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">The study, published in the
March 25, 2015 issue of ACS Applied Materials & Interfaces, reported the
newest coatings were crafted with what the researchers call a
"one-pot" process in which the ingredients were added to water,
heated and stirred until the solution became a gel, and then cooled. Depending
on the ingredients, preparation times ranged from about 30 minutes to two
hours.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">The
uncomplicated process could lend itself to industry adoption. However,
additional research is needed to determine the durability of the new coatings
and to assess other properties affecting performance and manufacturing
applications.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<i><span style="font-family: inherit;">For BCC Research flame
retardant chemicals report, visit the following link:<o:p></o:p></span></i></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div style="text-align: left;">
</div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/chemicals/flame-retardant-chemicals-report-chm014m.html"><span lang="EN-US">Flame Retardant Chemicals: Technologies and Global Markets</span></a></span> (<span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">CHM014M)</span></span><span style="font-size: 12pt;"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-72151846776775777922015-04-13T04:10:00.001-04:002015-04-13T04:10:35.743-04:00Proteomic Technologies Fueling Market Potential of Biofuels like Switchgrass<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="line-height: 115%;">A new
generation of fuel crops—plants designed specifically to serve as </span><span lang="EN-IN"><a href="http://newscenter.lbl.gov/2015/03/09/jbei-researchers-use-proteomics-to-profile-switchgrass/"><span style="line-height: 115%;">feedstocks
for fuels</span></a></span><span lang="EN-IN" style="line-height: 115%;">—would provide a clean, green and renewable
alternative to the burning of fossil fuels, but only if their production is
cost effective. These biofuels would </span><span lang="EN-IN" style="line-height: 115%;">require, among other developments, plants
whose sugars are readily extracted and fermented into fuels by microbes.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="line-height: 115%;"><span style="font-family: inherit;">Researchers with the
U.S. Department of Energy (DOE)’s Joint BioEnergy Institute (JBEI) have
demonstrated that proteomic technology may offer a way to harness this exciting
potential. Proteomics, a branch of the life sciences that studies proteins or
peptides, particularly their functions and interactions, specifically considers
technologies suited for large-scale, multiplexed analysis of proteins and
peptides. Proteomics differs from conventional protein analysis such as
immunoassay because it measures more than one protein or peptide simultaneously
from a single sample.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="line-height: 115%;"><span style="font-family: inherit;">Benjamin
Schwessinger, a grass geneticist with JBEI’s Feedstocks Division, and his
colleagues conducted the first proteomic analysis of switchgrass (<i>Panicum virgatum</i>), a North American
native prairie grass widely viewed as one of the most promising of all the fuel
crops. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="line-height: 115%;"><span style="font-family: inherit;">“Plant cell walls or
biomass are costly to deconstruct for sugar release for downstream applications
such as biofuels, but genetic modifications to plant cell wall structure could
result in significant downstream economic impacts,” Schwessinger explains. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span style="line-height: 115%;">In profiling the switchgrass
endomembrane from 10-day old dark grown shoots, Schwessinger and his team
identified 1,750 unique proteins in shoots of the hardy perennial crop.</span><span lang="EN-IN" style="line-height: 115%;"><o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span lang="EN-IN"><span style="font-family: inherit;">“That we were able to identify such a large number of proteins in our
samples shows that proteomics will be useful when we start digging for proteins
that will enable us to manipulate switchgrass for increased biofuel
production.”<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span lang="EN-IN"><span style="font-family: inherit;">The global proteomics market is expected to more than double its $5
billion value in 2014 to more than $11.6 billion in 2019, reflecting a
five-year compound annual growth rate (CAGR) of 18%. The main proteomics market
segments include research, drug discovery and development, diagnostics and
applied (agricultural, environmental and forensics).<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span lang="EN-IN"><span style="font-family: inherit;">The research/drug discovery and development segment of the market is
forecast to reach almost $6.8 billion in 2019, up from almost $4 billion in
2014, corresponding with an 11.4% CAGR. <o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Rapid changes in technical fields such as biochips,
<a href="https://www.blogger.com/null" name="_GoBack"></a>mass spectrometry, single cell analysis and multi-omics are
driving new products and applications in proteomics, creating unique market
opportunities. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For our BCC
Research report on proteomics, visit the following link:<o:p></o:p></span></span></i></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<br /></div>
<div style="text-align: left;">
</div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/biotechnology/proteomics-technologies-markets-report-bio034d.html">Proteomics: Technologies and Global Markets</a></span><span lang="EN-IN"> (</span><span lang="EN-IN" style="background: white;">BIO034D)</span></span><span lang="EN-IN" style="font-family: "Calibri","sans-serif"; mso-ascii-theme-font: minor-latin; mso-bidi-font-family: Arial; mso-bidi-font-weight: bold; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-18751732971789511372015-04-06T04:21:00.001-04:002015-04-06T04:21:39.738-04:00Research on Malaria Vaccines Showing Positive Results<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">A discovery of how the body’s immune system
protects against malaria may hold promise for a vaccine against the disease,
which kills as many as 600,000 people each year, mostly children. Currently, no
effective vaccine exists for the mosquito-borne disease, which infects the
bloodstream and red blood cells, leading to fatigue, headaches, and in severe
cases, death.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Antibodies play major roles in immunity to malaria,
but a limited understanding of mechanisms mediating protection long has been a
barrier to vaccine development. Researchers have known antibodies alone were
mostly ineffective at targeting the malaria organism, leading them to believe
the antibodies in people resistant to malaria must be getting help from other
parts of the immune system.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN" style="line-height: 115%;"><span style="font-family: inherit;">Professor
James Beeson, who heads Burnet’s Centre for Biomedical Research in Melbourne,
Australia, said he and his research team discovered that antibodies “needed to
recruit other proteins in the blood” in order to block malaria infection. This
mechanism, known as a complement,” helps the antibodies coat the malaria
organism, according to Beeson. “By working together,” he adds, “these two
things are a double-hit that stops malaria from infecting red blood cells.”<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN" style="line-height: 115%;"><span style="font-family: inherit;">The
findings represent a major advance in understanding immunity to malaria and
provide a much-needed strategy for the development and evaluation of vaccines.<a href="https://www.blogger.com/null" name="_GoBack"></a><o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">Beeson says Burnet’s researchers will now apply
this new knowledge to their strategies to create new and more effective </span><span lang="EN-IN"><a href="http://www.theguardian.com/society/2015/mar/18/malaria-antibodies-discovery-brings-vaccine-closer-to-reality-say-researchers">malaria vaccines</a></span><span lang="EN-IN">.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">“Exploiting this malaria-blocking activity is a new
approach in developing a vaccine. We have shown that it is possible to
effectively generate this protective immune response by immunizing humans with
a candidate vaccine,” Beeson says.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Historically, vaccines were developed to protect
against bacterial and viral diseases that plagued the world population through
the 1950s and 1960s. Diphtheria, tetanus, pertussis, polio, smallpox and
malaria, among others, were produced in mass quantities to treat large
populations.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">The advances in immunology, biochemistry,
microbiology and biotechnology during the past four decades have opened up the
possibilities of creating vaccines for a variety of diseases, including
Alzheimer’s, certain cancers, HIV, multiple sclerosis, various tropical
diseases, and autoimmune disorders such as diabetes, lupus erythematosus and
arthritis.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Vaccines are also being developed against new
targets, including Japanese encephalitis, meningitis, certain pollen allergies,
metastatic melanoma, Type I diabetes, oral rotavirus, hypertension, and
enterotoxigenic Escherichia coli infection.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Currently, researchers are conducting more than 640
clinical trials around the world on a wide variety of vaccines. The World
Health Organization estimates there are 120 new vaccines in
pharmaceutical/biopharmaceutical company pipelines.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">In the United States, the FDA will approve a
vaccine if there exist an adequate immunological response, patient safety and
established effectiveness of the vaccine at controlling the disease. Vaccine
development, approval and production are a costly and long-term venture for any
pharmaceutical company. It demands separate, dedicated facilities, equipment
and staff. This requires that there be potential revenue and large, diverse
patient populations to allow a company to enter into a vaccine venture.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: left;">
<br /></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left; vertical-align: baseline;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For our BCC
Research report on vaccines, visit the following link:<o:p></o:p></span></span></i></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: left;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/biotechnology/research-antibodies-global-markets-report-bio141a.html"><span lang="EN-US">Global Markets for Research Antibodies</span></a></span> (BIO141A)<o:p></o:p></span></div>
<div style="text-align: left;">
</div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<a href="http://www.bccresearch.com/market-research/biotechnology/biologic-therapeutic-drugs-technologies-markets-report-bio079c.html"><span style="font-weight: normal;"><span style="font-family: inherit;">Biologic Therapeutic Drugs:
Technologies and Global Markets</span></span></a><span style="font-weight: normal;"><span style="font-family: inherit;"> (<span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">BIO079C)</span></span><span style="font-family: Calibri, sans-serif; font-size: 12pt;"><o:p></o:p></span></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-74356823949095183252015-04-01T04:07:00.000-04:002015-04-01T04:07:00.829-04:00A New Perspective on Autism Spectrum Disorde<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">Two teams
of researchers from <span lang="EN-IN"><a href="http://www.bucknell.edu/"><span style="background: rgb(250, 250, 250);">Bucknell
University</span></a></span><span lang="EN-IN" style="background: rgb(250, 250, 250);"> </span>and its Geisinger Autism and Developmental Medicine
Institute (ADMI) are conducting different studies to explore the same thing:<a href="https://www.blogger.com/null" name="_GoBack"></a> how to diagnose autism earlier. Ultimately, the researchers
hope their work will lead to earlier clinical and therapeutic interventions for
children with neurodevelopmental disorders like autism.<span lang="EN-IN" style="background: rgb(250, 250, 250);"><o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">Autism
Spectrum Disorder (ASD) is a complex neurodevelopmental disorder characterized
by deficits in social and communication skills, and by abnormal coherence to
repetitive behaviors. Experts claim that ASD, which typically manifests before
age three, is the fastest-growing childhood development disorder (13% to 15%
annual growth).<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">Scientists
aren’t certain about what causes ASD, but it’s likely that both genetics and
environment play a role. Because of the unknown and complex nature of this
disorder, effective diagnosis and treatment of ASD has proven challenging. <o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">In one of
the studies, Aaron Mitchel, assistant professor of psychology at Bucknell, and his
research partners will investigate how two genetic causes of autism spectrum
disorder impact children's abilities to integrate visual, auditory and other
stimuli. They will examine multisensory integration, or the ability to connect
stimuli perceived with different senses.<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">"Previous
research on multisensory integration has studied dyslexia, ADHD, autism. It was
focused on behavioral diagnoses," Mitchel said. "We're going to the
heart of matter, to the genetic diagnoses to see if there is commonality." <o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">Rich
Kozick, professor of electrical and computer engineering at Bucknell, and
Andrew Michael, director<span lang="EN-IN"> of
ADMI’s neuroimaging analytics laboratory, </span>are studying methods for capturing the work of brain
networks using functional MRI technology. The researchers hope their work will
lead to a more accurate tool for diagnosing ASD.<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">Their
project draws upon the deep database of brain-imaging data available through
the ADMI, Michael's knowledge of brain imaging and Kozick's expertise in signal
processing, which he has previously applied to military and robotics projects.<o:p></o:p></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For our BCC Research report on autism spectrum disorder, visit the
following link:<o:p></o:p></span></span></i></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="line-height: 115%;"><a href="http://www.bccresearch.com/market-research/healthcare/diagnosis-therapies-autism-spectrum-disorders-markets-report-hlc181a.html"><span style="line-height: 115%;">Diagnostics and Therapeutics for Autism Spectrum
Disorders: Global Markets</span></a></span><span lang="EN-IN" style="line-height: 115%;"> (</span><span lang="EN-IN" style="background: white; line-height: 115%;">HLC181A)</span></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-51781800154443804132015-03-30T07:16:00.002-04:002015-03-30T07:16:35.257-04:00Make Way for Pizzicato—The New Wireless Technology on the Block<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">The world’s first </span>fully digital radio
transmitter<span lang="EN-IN"> promises to improve the wireless communications capabilities of
everything from 5G mobile technologies to the multitude devices aimed at
supporting the Internet of Things, or IoT (a </span>proposed
development of the Internet in which everyday objects have network connectivity
that allows <span lang="EN-IN">them to send and receive data).<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">Dubbed Pizzicato, the prototype radio consists of
an integrated circuit that outputs a single stream of bits, an antenna, and not
much else. It has </span>no conventional radio parts or digital-to-analogue
converter. <span lang="EN-IN">Algorithms perform the necessary ultra-fast computations in real
time, thus enabling standard digital technology to generate high frequency
radio signals directly.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">"Our first trial of the technology has created
14 simultaneous cellular base station signals," says Monty Barlow,
director of wireless technology with Cambridge Consultants, the product
development and technology consultancy firm which created Pizzicato. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">But it’s the digital technology of the
Pizzicato-based radio that excites Barlow. Like mainstream processing, he
explains, the device should benefit from Moore’s Law (the observation that
processor speeds, or overall processing power for computers will double every
two year), thus shrinking in cost, size and power consumption with each new
generation of silicon fabrication. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">“We believe that, in the same way that
microprocessors went from being expensive to being cheap enough to be installed
in many everyday items, our technology can do the same for radio systems,” he
adds. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">The implication looms large because of the limited
availability of radio spectrum bands, particularly in the more popular lower
frequency ranges (less than 1 GHz). Good radio spectrum is a scarce resource.
Only low frequencies (1GHz or lower) propagate well over distance or through
walls, so they are in great demand. Analog circuits or even the more advanced
analog-digital amalgams used in software-defined radio (SDR) are rapidly approaching
their limits.</span><span lang="EN-IN"> </span><o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">“Crowding 50 analogue radios together on one
chip, switching their operational parameters every few microseconds and
expecting them to work at 60GHz is an analogue designers nightmare,” Barlow
says.<o:p></o:p></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">One way to improve efficiencies at these
frequencies is the employment of dynamic switching capabilities to sense the
radio environment and switch various settings as required, in real time. In
other words, by using a type of "cognitive wireless" technique to
intelligently control the way that signals are sent and received, therefore,
make maximum use of the available spectrum. Cognitive radios are an evolution
of software-defined radios. They implement baseband processing functions in
software and use agile radio frequency (RF) front ends that can operate across
a wide range of frequencies.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="border: 1pt none windowtext; padding: 0in;">BCC Research, in its report on </span><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/information-technology/software-defined-radio-technologies-markets-report-ift113a.html"><span style="border: 1pt none windowtext; padding: 0in;">software-defined radios</span></a></span><span lang="EN-IN" style="border: 1pt none windowtext; padding: 0in;">, forecasts a market size of $56.3
billion in 2019, up from $47.7 billion in 2014, across the military and public
safety communications sectors.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN" style="border: 1pt none windowtext; padding: 0in;"><span style="font-family: inherit;">Greater efficiency requires the use of dynamic
or ‘cognitive wireless’ techniques to sense the radio environment and switch
parameters on the fly. This could give access to more of the estimated 90% of
the allocated spectrum which is not in use at any one time.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span style="font-family: inherit;"><a href="https://www.blogger.com/null" name="_GoBack"></a><span lang="EN-IN">Barlow adds finally, "if we’re going to get high-speed broadband to
every mobile phone in the world, we’ll need lots of tiny, high-performance
radios in those phones. The radios will be squashed together in a way that
analog just doesn’t tolerate, whereas a Pizzicato-like digital radio could also
be programmed to generate almost any combination of signals at any carrier
frequencies, nimbly adapting its behavior in a way that is impossible in conventional
radios.”<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="text-align: left;">
</div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span style="font-family: inherit;"><i><span lang="EN-IN">For more BCC Research information technology, visit </span></i><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/information-technology"><i>http://www.bccresearch.com/market-research/information-technology</i></a></span></span><i><span lang="EN-IN" style="font-family: "Calibri","sans-serif"; mso-ascii-theme-font: minor-latin; mso-bidi-font-family: Arial; mso-hansi-theme-font: minor-latin;"><o:p></o:p></span></i></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-39452990603604609102015-03-16T04:12:00.001-04:002015-03-16T04:12:48.862-04:00Combining Beauty with a Greener Tomorrow: Eiffel Tower is Now a Site of Wind Turbines<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">The Eiffel Tower
is greener than ever. The 125-year-old structure is partially powering itself,
thanks to two </span><span lang="EN-IN"><a href="http://www.care2.com/causes/the-eiffel-tower-is-now-a-powerful-wind-energy-machine.html">new wind turbines</a></span><span lang="EN-IN">. The turbines
will produce about 10,000 kilowatt hours of electricity annually, enough to
power the iconic tower’s commercial activity on the first floor, which is home
to restaurants, a souvenir shop, exhibits, and pavilions.<o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">For the City of
Lights, the turbines represent the first implementation of a series of sustainable
refurbishment upgrades to reduce Paris’s ecological footprint. Other planned green
enhancements to the world’s most famous tower include roof-mounted solar panels
to help meet the water heating needs of the pavilions, LED lighting on the
first floor to save energy, and a rainwater recovery system that not only
supplies water to the toilet facilities but also helps power the booster pumps that
pump water to the upper levels of the tower.<o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Urban Green Energy
(UGE), a New York-based renewable-energy design firm, designed and installed
the two VisionAIR5 vertical axis wind turbines earlier this year. Installing the
twin 17-foot structures 400 feet above ground level was no easy task for UGE.
Mounting the turbines required each component to be hoisted individually and
suspended by rope above the tower’s second level. In addition, the installation
unfolded at night to avoid interrupting the Eiffel Tower’s hours of public
operation, which closes at 11 p.m. daily.<o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">The new turbines are
whisper silent—literally--generating about 40 decibels of sound when running at
full speed. Not only are the
crescent-shaped turbines almost inaudible, they’re not readily visible, either.
The tri-blade turbines were specially painted a grey-brown to match the hue of
the iron lattice.<o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">As one of the most
desirable methods of renewable energy source in the world, wind energy and its
development has spurred significant growth in the global wind energy market. In
2014, the market reached $165 billion, up more than $30 billion from the
previous year. The market is expected to reach $250 billion in 2020, reflecting
a five-year compound annual growth rate (CAGR) of 7.2%. <o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For our BCC Research report on wind energy, visit the following link:<o:p></o:p></span></span></i></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div style="text-align: left;">
</div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/energy-and-resources/wind-energy-global-markets-report-egy058b.html">Wind Energy: Global Markets</a></span><span lang="EN-IN"> (</span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">EGY058B)</span></span><span lang="EN-IN" style="font-size: 12.0pt; mso-bidi-font-family: Arial; mso-bidi-font-weight: bold; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN; mso-font-kerning: 18.0pt;"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-34363412883760696632015-03-10T04:36:00.000-04:002015-03-10T04:36:08.269-04:002015 Flame Conference - The Complete Technical and Commercial Development Meeting on Flame Retardancy<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span style="line-height: 107%;">World-renowned researchers will discuss their work and
discuss the latest developments related to flame retardancy at the </span><a href="http://www.bccresearch.com/conference/flame"><span style="line-height: 107%;">26<sup>th</sup> BCC Meeting on Flame Retardancy</span></a><span style="line-height: 107%;">, scheduled May 18–20, 2015, at the
Sheraton Hotel in Stamford, CT. This premier
industry event, which includes participants from the United States, France,
England, Italy, Hungary, Republic of Korea, and People’s Republic of China,
offers an ideal blend of experts from government/academia and the commercial/industrial
sectors. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="line-height: 107%;"><span style="font-family: inherit;">Conference sessions cover the entire spectrum of flame
retardancy: Commercial Products, Foams and Fabrics, Nanocomposites, Phosphorus-based
Flame Retardants, New Flame Retardants and Flame Retardants for Specific Polymers,
and Instrumentation. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="line-height: 107%;"><span style="font-family: inherit;">Experts in Commercial Products will discuss cutting-edge
research on flame retardancy materials in products such as television sets,
lithium ion batteries, furniture, airplanes and printed circuit boards. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="line-height: 107%;"><span style="font-family: inherit;">In Foams and Fabrics, one of the fastest growing categories of
flame retardancy, experts will offer state-of-the-art information on all types
of foams and fabrics, ranging from the layer-by-layer approach to how these
materials burn. Ten sessions are offered in this vibrant category.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="line-height: 107%;"><span style="font-family: inherit;">Experts in Nanocomposites, a category highlighted by the
growing use of nano-dimensional materials, will discuss materials such as clays,
layered double hydroxides, carbon nanotubes, POSS (polyhedral oligomeric
silsesquioxanes), and zirconium phosphate. Eight information-packed sessions
are offered in this rapidly expanding category.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="line-height: 107%;"><span style="font-family: inherit;">In the Phosphorus section, both academia and industry experts
will discuss basic research findings on new compounds, along with information
on how to market these products. Since legislation has restricted the use of bromine
(and chlorine) compounds, once the most common flame retardants, phosphorus
compounds have become one of the most researched and commercialized flame
retardants. Seven sessions will address this dynamic category. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="line-height: 107%;"><span style="font-family: inherit;">Experts in New Flame Retardants and Flame Retardants for Specific
Polymers will cover topics ranging from intrinsically highly flammable
retardant polymers to the flame retardancy of EVA and polyurea. Six sessions
will present the latest innovations in this category. <o:p></o:p></span></span></div>
<br />
<div class="MsoNormal" style="text-align: justify;">
<span style="line-height: 107%;"><span style="font-family: inherit;">In the Instrumentation section, experts will discuss how to
develop flame retardants for polymers, and how to evaluate them using the
required instrumentation. Five sessions are scheduled in this category.</span><span style="font-size: 12pt;"><a href="https://www.blogger.com/null" name="_GoBack"></a><o:p></o:p></span></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-70525303177425948772015-03-05T02:59:00.001-05:002015-03-05T02:59:18.767-05:00Treating Cancer Tumors is One Implantable Device Away<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Chemotherapy stops
or slows the growth of cancer cells, but it also damages healthy cells. Researchers
are exploring treatments that attack cancer cells with better precision, thus
reducing the risk of harming healthy tissue. A team of scie<a href="https://www.blogger.com/null" name="_GoBack"></a>ntists
has developed just such a technique, called iontophoresis, which uses an
electric field to deliver high concentrations of chemotherapy to select areas.<o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">"A big
challenge with many drugs is getting them where they need to go," said
Lissett Bickford, assistant professor in the Department of Biomedical
Engineering at Virginia Tech and a co-author of the study.
"(Iontophoresis) basically forces drugs directly to and through the tumor,
allowing all cancer cells in the treatment zone to get that exposure."<o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Iontophoresis uses
an electric field to push drugs into the tumor. A small device that generates
the electric field is implanted in the tumor or placed on the skin. The device
also contains a reservoir of chemotherapy. When activated, the electric field
pushes the drug into the entire tumor.<o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">In mice with human
inflammatory breast cancer, treatment with both iontophoresis and regular
intravenous chemotherapy increased survival time as compared with either
treatment alone. Treating mice with iontophoresis after intravenous
chemotherapy treatment boosted the concentration of the drug in the tumor, but barely
raised the concentration in the blood plasma. This indication suggests there
could be fewer side effects, an all-too-common complaint associated with
chemotherapy. <o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">The researchers
say iontophoresis effectively delivered the drug despite pressure from the
surrounding area of the tumor, a common complication in drug treatment
strategies. This pressure, which is caused by leaks from the blood vessels of
the tumor, often inhibits or complicates other drug delivery strategies.<o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Iontophoresis could
allow doctors to use more potent cancer-fighting drugs by localizing their
effects or pave the way for new multi-drug combinations by better aiming the
more toxic compounds at the tumor and freeing the rest of the body from their
harmful effects.<o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">"This may
ultimately lead to a reduction in the morbidity and mortality rates commonly
found in different types of cancer," says James Byrne, lead author of the
study and a postdoctoral researcher and medical student at the University of
North Carolina.<o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">According to a BCC
Research report (BIO048C), newer therapies like iontophoresis and others will surpass
conventional cancer therapies and propel sales in the global cancer therapy
market to $111 billion in 2019. The U.S. National Institutes of Health estimated
the overall cost of cancer in the United States was $206.3 billion in 2006, with
$78.2 billion in direct medical costs.<o:p></o:p></span></span></div>
<div style="margin: 0in 0in 0.0001pt; text-align: left;">
<br /></div>
<div style="margin: 0in 0in 0.0001pt; text-align: left;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For our BCC
Research reports on cancer, visit the following links:<o:p></o:p></span></span></i></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/pharmaceuticals/cancer-vaccines-technologies-global-markets-report-phm173a.html">Cancer Vaccines:
Technologies and Global Markets</a></span><span lang="EN-IN"> (PHM173A)</span><span lang="EN-IN"><o:p></o:p></span></span></div>
<div style="background: white; margin: 0in 0in 0.0001pt; text-align: left;">
<span style="font-family: inherit; font-size: small;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/biotechnology/biological-therapies-cancer-technologies-markets-report-bio048c.html"><span style="font-weight: normal;">Biological Therapies for Cancer:
Technologies and Global Markets</span></a></span><span lang="EN-IN"> </span><span lang="EN-IN" style="font-weight: normal;">(BIO048C)<br /><o:p></o:p></span></span><span style="font-family: inherit; font-size: small;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/radiotherapy-technologies-markets-report-hlc176a.html"><span style="font-weight: normal;">Radiotherapy: Technologies and
Global Markets</span></a></span><span lang="EN-IN"> </span><span lang="EN-IN" style="font-weight: normal;">(HLC176A)<br /><o:p></o:p></span></span><span style="font-family: inherit; font-size: small;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/breast-cancer-diagnostics-drug-technologies-report-hlc106b.html"><span style="font-weight: normal;">Breast Cancer Diagnostic and Drug
Technologies: Global Markets</span></a></span><span lang="EN-IN"> </span><span lang="EN-IN" style="font-weight: normal;">(HLC106B)<o:p></o:p></span></span></div>
<div style="text-align: left;">
</div>
<div style="margin: 0in 0in 0.0001pt; text-align: left;">
<span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/pharmaceuticals/therapeutics-silent-cancers-report-phm169a.html"><span style="font-family: inherit;">Therapeutics for
'Silent' Cancers</span></a></span><span lang="EN-IN"><span style="font-family: inherit;"> (PHM169A)</span><span style="font-family: Calibri, sans-serif;"><o:p></o:p></span></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-43493711050275581092015-02-24T07:03:00.000-05:002015-02-24T07:03:09.089-05:00A Green Innovation that Protects and Strengthens: Eco-Friendly Flame Retardant for Timber Buildings<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">In Australia, the effects of global warming
have raised concerns about the methods used to fire-proof buildings made of
timber, a necessary precaution in a country whose torrid summer heat and
parched climate pose significant fire hazards. However, most of the current methods
for <span style="background: #FCFCFC;">fire-proofing timber materials involve substances
that are toxic to human health and the environment.<o:p></o:p></span></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">Flame retardants rely on chemical reactions
that impede the ignition of flammable materials and slow the spread of a fire.
But the benefits</span><span lang="EN-IN"> of safeguarding homes and property while protecting
humans from fire danger must be weighed against the risk of exposure to potentially
harmful chemicals</span><span lang="EN-IN">.<span style="background: #FCFCFC;"> <o:p></o:p></span></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background: #FCFCFC; mso-bidi-font-family: Arial;">To address that challenge,
r</span><span lang="EN-IN">esearchers from
Stony Brook University have developed <span style="background: #FCFCFC;">a </span></span><span lang="EN-IN"><a href="http://sourceable.net/sustainable-flame-retardant-timber-buildings/"><span style="background: #FCFCFC; mso-bidi-font-family: Arial;">new type of timber
flame retardant</span></a></span><span lang="EN-IN" style="background: #FCFCFC; mso-bidi-font-family: Arial;"> that’s not only sustainable and environmentally
friendly, but also increases the strength of treated materials dramatically. </span><span lang="EN-IN">The flame retardant consists
of a phosphorus-based compound called resorcinol bis (RDP), which the Environmental
Protection Agency (EPA) has declared a preferred substitute for halogenated
flame retardants. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN" style="background: #FCFCFC; mso-bidi-font-family: Arial;"><span style="font-family: inherit;">According to Miriam
Rafailovich, Distinguished Professor from Stony Brook's Department of Materials
science and co-direc<a href="https://www.blogger.com/null" name="_GoBack"></a>tor of the Program in Chemical and
Molecular Engineering, the compound penetrates the natural structure of timber
materials and interacts with its cellulose, producing a wood-plastic
composite that surpasses UL94 V-0 flammability standards. This means
that a vertical specimen of the material will stop burning in as few as
10 seconds when set alight, without giving off any lit particles.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">"The breakthrough was in the
formulation of a compound that extinguishes a flame without decomposing into
toxic byproducts," Rafailovich said.<span style="background: #FCFCFC;"><o:p></o:p></span></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN" style="background: #FCFCFC; mso-bidi-font-family: Arial;"><span style="font-family: inherit;">Testing by Stony Brook
medical experts also concluded that timber materials treated using RDP pose
no hazard to human health, despite the material itself being cytotoxic
when in a liquid, unreacted state. Another advantage of the treatment process
is that can dramatically improve the durability of timber materials
by reinforcing their cellulose structure, increasing their strength by as much
as five-fold. The university has filed an application for patent acquisition. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background: #FCFCFC; mso-bidi-font-family: Arial;">According to a BCC
Research report, global </span><span lang="EN-IN">c</span><span lang="EN-IN">onsumption of flame retardant</span><span lang="EN-IN"> chemicals should reach 5 billion
pounds in 2018, nearly a billion more than the level </span><span lang="EN-IN">in 2013. The
report forecasts a compound annual growth rate (CAGR) of 5% between 2013 and
2018. Cost, performance, lack of toxicity,
recycling concerns and the push toward more green and non-halogenated products
will influence the smallest to the largest manufacture</span><span lang="EN-IN">rs of flame
retardant chemicals.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For our BCC
Research reports on flame retardant chemicals, visit the following links:<o:p></o:p></span></span></i></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/chemicals/flame-retardant-chemicals-chm014l.html">Flame
Retardant Chemicals: Technologies and Global Markets</a></span><span lang="EN-IN"> (</span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">CHM014L)</span><span lang="EN-IN"><o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/plastics/wood-plastic-composites-technologies-report-pls034c.html"><span lang="EN-US">Wood-Plastic
Composites: Technologies and Global Markets</span></a></span> (PLS034C)<span lang="EN-IN" style="background: #FCFCFC; mso-bidi-font-family: Arial;"><o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: left;">
<i><span style="font-family: inherit;">Related
conference<o:p></o:p></span></i></div>
<div style="text-align: left;">
</div>
<div class="MsoNormal" style="text-align: left;">
<span lang="EN-IN"><a href="http://www.bccresearch.com/conference/flame"><span lang="EN-US"><span style="font-family: inherit;">26th Annual
Conference: Recent Advances in Flame Retardancy of Polymeric Materials</span></span></a></span><span lang="EN-IN"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-85592810126788397072015-02-19T05:26:00.001-05:002015-02-19T05:26:14.013-05:00No Pain Doubles the Gain: Cost-Efficient Needle-Free Technology Transforming the Healthcare Industry<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">For years researchers have sought alternatives to the finger-pricking
method for measuring blood glucose levels. People with diabetes typically test
their glucose levels several times a day by pricking their finger and analyzing
their blood. But the pain of this constant finger-pricking drives many patients
to avoid checking their blood sugar levels, which places them at higher risk
for poor health.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">Needle-free devices and technologies offer
alternatives to needles and syringes that avoid the issues of needle phobia,
needlestick injuries and the transmission of blood-borne diseases. Because
needle-free devices are painless, effective and safe drug delivery methods,
pharmaceutical companies will continue to invest billions on new delivery
technologies during the next five to 10 years. Also, c</span><span lang="EN-IN">ontinuous innovation and availability of newer needle-free drug delivery
systems have the potential to deliver highly viscous drug products that
traditional needle and syringe methods are unable to administer, adding to the
utility of the technology.</span><span lang="EN-IN"><o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span style="font-family: inherit;"><a href="https://www.blogger.com/null" name="_GoBack"><span lang="EN-IN">In the glucose
monitoring segment of the needle-free drug delivery market, a new invention may
offer people with diabetes relief from the pain of the finger-pricking method. </span></a><span lang="EN-IN">Researcher Amay
Bandodkar and his colleagues at Professor Joseph Wang’s laboratory at the
University of California at San Diego have created a </span><span lang="EN-IN"><a href="http://www.theatlantic.com/health/archive/2015/01/the-temporary-tattoo-that-tests-blood-sugar/384581/">flexible sensor</a></span><span lang="EN-IN"> that measures a
person’s blood sugar levels using a mild electrical current. The device, a thin tattoo paper printed with
electrodes of silver and silver chloride ink and a blood glucose sensor made of
a glucose-sensitive enzyme, is applied to the skin like a rub-on tattoo. A mild
electrical current applied to the skin for 10 minutes draws sodium ions, which
carry glucose molecules, from the fluid between skin cells toward the
electrodes. The sensor in the tattoo then measures the strength of the
electrical charge produced by the glucose to determine blood sugar levels. <o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">The tattoo sensor currently doesn’t provide a readout of glucose measures
(the device has to be removed and analyzed for that), but researchers are working
on that particular feature. According to Bandodkar, “The readout instrument
will also eventually have Bluetooth capabilities to send this information
directly to the patient's doctor in real-time, or store data in the cloud. The
team is also working on ways to make the tattoo last longer while keeping its
overall cost down, he added. In its current form, the device lasts for about a
day and costs a few cents. <o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">Needle-free devices like the tattoo sensor and other technologies are
driving growth in the needle-free drug delivery markets. The global market for </span><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/needle-free-devices-technologies-markets-report-hlc178a.html">needle-free drug
delivery technologies</a></span><span lang="EN-IN"> is expected to almost double from <span style="background: white;">$1.1 billion in 2014 to $2.1 billion in 2019,
reflecting a compound annual growth rate (CAGR) of 14.3%. Within the
needle-free device and technology market, t</span>he needle-free injector
segment is anticipated as one of the fastest growing segments.</span><span lang="EN-IN"><o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For our BCC
Research report on needle-free drug delivery technologies, visit the following
link:<o:p></o:p></span></span></i></div>
<div style="text-align: left;">
</div>
<div class="MsoNormal" style="background: white; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/needle-free-devices-technologies-markets-report-hlc178a.html">Needle-Free Devices, Technologies and Global Markets</a></span><span lang="EN-IN"> (</span></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"><span style="font-family: inherit;">HLC178A)</span><span style="font-size: 12pt;"><o:p></o:p></span></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-39452638355470492052015-02-09T02:16:00.002-05:002015-02-09T02:16:22.711-05:00Breast Cancer Deaths Declining as Detection and Treatment Improve<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">According to <a href="http://globocan.iarc.fr/Default.aspx">GLOBOCAN
2012</a>, there were 14.1 million new cancer cases, 8.2 million cancer deaths
and a staggering 32.6 million people living with cancer (within five years of
diagnosis) worldwide in 2012. The World Health Organization (WHO) has stated
that currently, about one-third of the world’s cancer burden can be decreased
if cancer cases are detected earlier and treatment is provided immediately.</span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;"><br /></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Breast cancer in particular is the second-leading cause of cancer
death in women with nearly 1.7 million new cases diagnosed worldwide in 2012. .
According to the National Cancer Institute (NCI), more than 200,000 women in
the U.S. are diagnosed with breast cancer annually. </span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background: white;">Early detection and new treatments have
improved survival rates for breast cancer patients, helping the five-year
survival rate for women diagnosed with cancer to reach nearly 80%. Death rates
from breast cancer have been declining since about 1989; these decreases are
believed to be the result of earlier detection through screening and increased
awareness, as well as improved treatment. Sales of </span><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/breast-cancer-diagnostics-drug-technologies-report-hlc106b.html"><span style="background: white;">breast cancer diagnostic and drug technologies</span></a><span style="background: white;"> reached about $22.3 billion globally in 2014 and are expected
to reach $27 billion in 2019, equating to a compound annual growth rate (CAGR)
of 4% (2014–2019). </span></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">According to <a href="http://www.elcaminohospital.org/">El Camino Hospital</a>’s Radiologist
Dr. Sila Yitta, routine mammograms and self-screening are the best defense,
although many women don't always take advantage. "In my experience it is
hit or miss; some women are consistent in doing breast exams at home, some
women don't do them at all," Yitta said.</span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">New experimental technology could
help thousands of women and doctors screen for breast cancer in a new way,
revolutionizing the screening process. A device called <a href="http://abc7news.com/health/high-tech-bra-helps-detect-breast-cancer/496449/">iTBra</a><span class="MsoHyperlink"> by </span><a href="http://bit.ly/1LoRORz">Cyrcadia Health</a>
is about to begin its clinical trials in the Bay Area, California, USA. Rather
than a mammogram or ultrasound, this system can be used at home, with
potentially life-saving information transmitted through a smartphone.<br />
<!--[if !supportLineBreakNewLine]--></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in;">
<span style="font-family: inherit;"><span lang="EN-IN"><br /></span><span lang="EN-IN"><br /></span><span lang="EN-IN">
The clinical trial being conducted at El Camino Hospital will study the results
on women wearing the device for different lengths of time. The goal is to
produce accurate readings in roughly two hours, ultimately making the system
more convenient for women to use. <a href="https://www.blogger.com/null" name="_GoBack"></a>If the trial is
successful, Cyrcadia Health hopes to have the iTBra on the market later this
year.</span><br /><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/pharmaceuticals/cancer-vaccines-technologies-global-markets-report-phm173a.html"><span style="font-weight: normal;">Cancer Vaccines: Technologies and Global Markets</span></a></span><span lang="EN-IN" style="font-weight: normal;"> (<span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">PHM173A)<o:p></o:p></span></span></span></div>
<br />
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Cyrcadia Health CEO Rob Royea
says, "It's a wearable device with a number of sensors that check what
happens with your circadian patterns of heat change on your breast over
time." The results are then processed using sophisticated algorithms and
transmitted to a smartphone. "You wear the device for a few hours, and
that information is automatically communicated to your physician," Royea
added.</span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Because the system is heat based,
developers believe it may also offer advantages for some women with denser
breast tissue, which can be more difficult to image using traditional
mammography.</span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">In addition to R&D efforts in early detection, improved cancer
treatment is making a difference as well, resulting in fewer mastectomies. "The
therapeutic approaches to breast cancer have changed radically since the
1990s," say Stefano Zurrida, MD, and Umberto Veronesi, MD, from the </span><span lang="EN-IN"><a href="http://www.eso.net/pagine-interne/clinical-training-centres-ieo.html">European
Institute of Oncology</a></span><span lang="EN-IN"> in Milan, "and the pace of change
shows no signs of slacking."<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: left;">
<i><span lang="EN-IN" style="line-height: 115%;"><span style="font-family: inherit;">For related BCC Research market
analysis reports on breast cancer, visit the following links:<o:p></o:p></span></span></i></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/breast-cancer-diagnostics-drug-technologies-report-hlc106b.html">Breast Cancer Diagnostic and Drug Technologies: Global
Markets</a></span><span lang="EN-IN"> (</span></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"><span style="font-family: inherit;">HLC106B)</span><span style="font-size: 12pt;"><o:p></o:p></span></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-59464900288725660972015-01-13T02:16:00.001-05:002015-01-13T02:16:25.633-05:002015 FLAME CONFERENCE - Recent Advances in Flame Retardancy of Polymeric Materials<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Losses caused by fire are
disastrous. Most notable are the victims and firefighters who are killed and
injured. Displacement and devastation of property can be significant. Economic
losses are huge; countries globally spend a not-insignificant portion of their
GDP on loss, prevention, and firefighting. Accordingly, there are people and
companies worldwide dedicated to fire prevention and protection, and the development
of fireproof, non-burning, flame retardant, and flame resistant materials,
without whom the losses would be orders of magnitude greater. We salute them.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">For 25 years, BCC Research has
hosted “<a href="http://www.bccresearch.com/conference/flame" target="_blank">the Flame Conference</a>,” as a forum for people in the fire retardant (FR)
industry to meet, share, and learn from each other. The conference – called Annual Conference on Recent Advances in Flame
Retardancy of Polymeric Materials – focuses on the development of flame
retardant chemicals and materials such as plastics, textiles, and surface
coatings that inhibit, suppress, or delay the production of flames to prevent
the spread of fire. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Now in its 26<sup>th</sup> year, the Flame
Conference is the premier fire retardant (FR) event in the United States. It
brings together scientists and other technical specialists for an intensive
seminar that fosters learning and networking among the industry’s best and
brightest. The single track of sessions covers both the government/academia and
commercial/industrial sectors.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">“If you want to know about the latest
breakthrough in flame retardant research, the Flame Conference is the
conference to attend,” said one of the Conference’s attendees in 2014. Another
commented, “…it was very good to hear from companies… that offer real world
products that are cost effective.... Everything starts in the lab but at some
point it has to be viable for the market not just in efficacy but in cost,
processing, and value in use.”<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN" style="background: white;"><span style="font-family: inherit;">The 2015 Flame Conference is scheduled to
be held from May 17<sup>th</sup> to 20<sup>th</sup>, 2015 in Stamford,
Connecticut, USA. Register now to take advantage of this opportunity as seating
is limited. Each year this intelligent and intimate conference brings back many
of the same attendees, who rely on it as an irreplaceable and on-point source
of knowledge about the science, technology, design, and manufacture of
flame-retardant materials and coatings.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><i><span lang="EN-IN" style="background: white;">For
information on the <a href="https://www.blogger.com/null" name="_GoBack"></a>2015 Flame Conference, visit</span></i><span lang="EN-IN" style="background: white;"> </span><span lang="EN-IN"><a href="http://www.bccresearch.com/conference/flame"><span style="background: white;">http://www.bccresearch.com/conference/flame</span></a><span style="background: white;"><o:p></o:p></span></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For information on a BCC Research
report on the flame retardant chemicals market, visit <o:p></o:p></span></span></i></div>
<div style="text-align: left;">
</div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/chemicals/flame-retardant-chemicals-chm014l.html"><span style="font-family: inherit;">http://www.bccresearch.com/market-research/chemicals/flame-retardant-chemicals-chm014l.html</span></a></span><span lang="EN-IN"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-70581948893903580812014-11-25T02:49:00.001-05:002014-11-25T02:49:22.108-05:00Will Gene-edited Stem Cells Hold the Key to Fighting HIV/AIDS?<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background: white; border: 1pt none windowtext; padding: 0in;">In a research conducted at Harvard
University, a </span><span lang="EN-IN"><a href="http://timesofindia.indiatimes.com/home/science/Editing-blood-stem-cells-to-fight-HIV/articleshow/45077033.cms?"><span style="background: white; border: 1pt none windowtext; padding: 0in;">new gene-editing technique</span></a></span><span lang="EN-IN" style="background: white; border: 1pt none windowtext; padding: 0in;"> was used to create what
could prove to be an effective method for blocking HIV from invading and
destroying patients' immune systems.</span><span class="apple-converted-space"><span lang="EN-IN" style="background: white;"> </span></span><span lang="EN-IN" style="background: white;">The work was led by Chad
Cowan and Derrick Rossi, Associate Professors in </span><span lang="EN-IN"><a href="http://www.scrb.harvard.edu/"><span style="background: white;">Harvard's Department of Stem Cell and Regenerative Biology</span></a></span><span lang="EN-IN" style="background: white;"> (HSCRB).<span class="apple-converted-space"> <o:p></o:p></span></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background: white;">This is the first
published report of the Harvard researchers using </span><span lang="EN-IN"><a href="http://en.wikipedia.org/wiki/CRISPR"><span style="background: white;">CRISPR/Cas technology</span></a></span><span lang="EN-IN" style="background: white;"> to efficiently and precisely edit
clinically relevant genes out of cells collected directly from people, in this
case human blood-forming stem cells and T-cells, researchers said.<span class="apple-converted-space"> </span></span><span lang="EN-IN"><br />
<br />
<span style="background: white;">In theory, such gene-edited stem cells could be
introduced into HIV patients via bone marrow transplantation—the procedure used
to transplant blood stem cells into leukemia patients, to give rise to
HIV-resistant immune systems.<span class="apple-converted-space"> </span></span><br />
<br />
</span><span lang="EN-IN" style="background: white; mso-bidi-font-family: Arial; mso-bidi-font-weight: bold;">Human Immunodeficiency Virus or <em><span style="font-style: normal;">Acquired
Immune Deficiency Syndrome (</span></em></span><span lang="EN-GB">HIV/AIDS) is one of the most
catastrophic threats to human health in the world. Improved treatment options
and methods of diagnosis have helped to moderate the growth of the epidemic,
presenting opportunities for companies prepared to engage actively in this
field. However, the management of HIV/AIDS is still, in many respects, a very
significant threat, and there is an ongoing, urgent need for promising new
research as well as optimal exploitation of the treatment and diagnostic
options already developed.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-GB"><span style="font-family: inherit;">According to the Joint United Nations Programme on HIV and AIDS
(UNAIDS), there were 35 million people across the globe living with human
immunodeficiency virus (HIV) in 2012. In 2012, 1.6 million people died of
HIV/AIDS, including 1.2 million AIDS-related deaths in sub-Saharan Africa. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-GB"><span style="font-family: inherit;">According to a BCC Research report, in 2012 the HIV therapeutics market
was worth $17.5 billion. The global market is expected to peak at $20.9 billion
in 2016 and will shrink back to $19.6 billion in 2018, representing an overall
compound annual growth rate (CAGR) of 1.5%. The patent expiration of leading
antiretroviral drugs and the subsequent introduction of generic drugs will
create cost pressures that will drive overall revenues down, resulting in
suppressed market revenue growth.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN" style="background: white;"><span style="font-family: inherit;">Though this new approach
to HIV therapy might be ready for human safety trials in less than five years, the
researchers are still cautious about celebrating victory.<span class="apple-converted-space"> </span>Even if this new approach works
perfectly, further developments need to be carried out before they are
introduced in the global market.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><i><span lang="EN-IN">For
more information on a BCC Research market report about HIV </span></i><i><span lang="EN-IN" style="background: white;">therapeutics and
diagnostics</span></i><i><span lang="EN-IN">, visit the following link:<o:p></o:p></span></i></span></div>
<br />
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/pharmaceuticals/hiv-diagnostics-therapeutics-phm058b.html"><span style="background: white;"><span style="font-family: inherit;">http://www.bccresearch.com/market-research/pharmaceuticals/hiv-diagnostics-therapeutics-phm058b.html</span></span></a></span><span lang="EN-IN" style="background: white; font-size: 12.0pt;"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-10514823720315753932014-11-14T02:50:00.001-05:002014-11-14T02:51:14.136-05:00Growing Prevalence of a Silent Killer— Diabetes <div dir="ltr" style="text-align: left;" trbidi="on">
<div class="storycopy" style="background: white; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">The number of
people around the world suffering from diabetes has skyrocketed in the last two
decades, from </span><span lang="EN-IN"><a href="http://www.nytimes.com/2006/06/11/health/11diabetes.html?_r=2&"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">30 million to 230 million</span></a></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">, claiming
millions of lives and severely taxing the ability of health care systems to
deal with the epidemic, according to data released by the </span><span lang="EN-IN"><a href="http://www.idf.org/"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">International Diabetes Federation</span></a></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">. </span><span lang="EN-IN">The demographics of the diabetes epidemic
are also changing rapidly at the same time. While the
growing problem of diabetes in the United States has been well documented, the
federation’s data shows that 7 of the 10 countries with the highest number of
diabetics are in the developing world.<span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"><o:p></o:p></span></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span lang="EN-GB"><span style="font-family: inherit;">Type I diabetes is an autoimmune disease; it appears in childhood, is
lifelong, and currently must be treated with insulin. Type II diabetes typically
appears in middle age. It is linked to obesity and therefore is more prevalent
in developed countries with relatively affluent lifestyles, sedentary
occupations, and dietary overindulgence.
<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">According to the American
Diabetes Association's journal, </span><span lang="EN-IN"><a href="http://care.diabetesjournals.org/help/">Diabetes
Care</a></span><span lang="EN-IN">, Asia accounts
for 60% of the world's diabetic population.</span><span lang="EN-IN"> </span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">In recent decades, Asia
has undergone rapid economic development, urbanization, and transitions in
nutritional status. </span><span lang="EN-IN">China
now has the largest number of diabetics over age 20, around 39 million people
or about 2.7 percent of the adult population, according to the federation. The
group also mentions India with the second largest number of cases with an
estimated 30 million people, or about 6 percent of the adult population.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">There are many
factors driving the growth in diabetes worldwide, but most experts agree that
changes in lifestyle and diet are the chief culprits, in addition to genetic
predisposition. As developing countries rapidly industrialize, people tend to
do work involving less physical activity. At the same time, the availability of
food that is cheap but high in calories becomes more common.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">Typically, </span><span lang="EN-IN"><a href="http://www.medicalnewstoday.com/articles/250792.php?sr"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">type II diabetes</span></a></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"> occurs after a person
becomes obese, when insulin resistance occurs; the diabetes comes next. When this occurs, the
cells do not respond properly to insulin; glucose does not enter the cells and
blood glucose (sugar) levels rise. When fat is stored in the "wrong"
places (blood vessels, heart and muscles) in the body, insulin resistance is
much more likely to occur. Experts are not sure exactly how the association
works. <o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">The most common treatment for type II diabetes today involves initially
placing the patient on a special diet; sometimes they may need to take pills that
increase insulin secretion and also make the cells more sensitive to insulin.
Occasionally they are given tablets to bring down the production of glucose.
However, after a few years, for about one-third of all patients these
treatments gradually lose their efficacy and insulin injections are needed.<span class="apple-converted-space"> </span></span><span lang="EN-IN"><br />
</span></span></div>
<span style="font-family: inherit;"><span lang="EN-IN"><br /></span></span><span style="font-family: inherit;"><span lang="EN-IN"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1pt none windowtext; padding: 0in;">The most effective
treatment today, however, to prevent type II diabetes onset among very obese
patients is </span></span><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/bariatric-surgery-markets-hlc153a.html"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1pt none windowtext; padding: 0in;">bariatric surgery</span></a></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">. </span></span><br />
<br />
<div class="storycopy" style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">World-renowned British specialist </span><span lang="EN-IN"><a href="http://www.express.co.uk/life-style/health/532841/Simple-lifestyle-changes-stop-Britain-s-diabetes-crisis">Dr David Cavan</a></span><span lang="EN-IN">, Director of policy at the International Diabetes
Federation, hands patients a lifeline with a simple regime that can reduce the
devastating effects of type II diabetes. His plan includes adopting a healthy
diet, getting support from your family, boosting exercise, assessing current
diabetes drugs, keeping up to date with monitoring the condition – and,
finally, being realistic about what you want to achieve.<o:p></o:p></span></span></div>
<div class="storycopy" style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">According to Dr Cadan, people with type II diabetes
will be motivated to change their lifestyle if they realize that it is possible
to become free from diabetes rather than if they think that whatever they do,
they will always have it. He added that reducing sugar and understanding that
some starchy carbohydrates have almost the same effect as eating sugar can
bring about swift changes.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-GB">According to the International Diabetes Federation and other major
professional organizations, the global population of individuals with diabetes
(type I and II) was about 240 million in 2010, and is expected to rise to 300
million by 2025. The corresponding
market of products used to diagnose and treat diabetes was </span><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/diabetes-therapeutics-diagnostics-markets-hlc029d.html"><span lang="EN-GB">$118.7 billion for
2012</span></a></span><span lang="EN-GB">, and is expected to rise to almost $157 billion over the next five
years. The market for monitoring
equipment stands at approximately $14 billion and is set to rise toward $21
billion by 2017.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"><span style="font-family: inherit;">Working towards introducing innovative solutions in this area, French
pharmaceutical company, Servier, is planning to pioneer a tiny drug-loaded
implantable pump, developed by a Boston-based start-up, Intarcia Therapeutics
Inc., which is anticipated to transform the global market for patients with
diabetes.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"><span style="font-family: inherit;">Servier has agreed to pay Intarcia Therapeutics Inc. $171 million up
front, with potential additional payments that could increase the total to more
than $1 billion, for rights to co-develop the device for most markets outside
the U.S., the companies said. Closely held Intarcia retains full rights to the
treatment for the U.S. and Japan. The pump hasn’t yet been approved for sale;
the companies plan to submit it to regulators in the first half of 2016.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<br /></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; color: #111111;">In Sweden, the researchers from Stockholm University say that
they have uncovered a </span><span lang="EN-IN"><a href="http://www.medicalnewstoday.com/articles/285231.php"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">new mechanism</span></a></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; color: #111111;"> that
encourages glucose uptake in brown fat. They explain that brown fat's main
function is to create heat by burning fat and sugar. By using this new
knowledge, the researchers say they may be able to stimulate this signalling
pathway with drugs, lowering blood sugar levels and potentially even curing
type II </span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 1pt none windowtext; padding: 0in;">diabetes</span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; color: #111111;">. <o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 6.0pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">The brown fat is active in adults, acting as one of the bodily tissues
that can be encouraged to take up large amounts of glucose from the bloodstream
to use as a fuel source to create body heat, the researchers said. As such,
increasing the uptake of glucose in brown fat can quickly decrease blood sugar
levels, they added.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 6.0pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">In a person with the condition, the body's tissues are unable to
respond to insulin, rendering them unable to take up sugar from the blood.
Because insulin is released after eating to regulate blood sugar, when the
insulin signal no longer functions properly, blood sugar levels rise. Very high
blood sugar levels are dangerous to organs in the body and can lead to<span class="apple-converted-space"> </span></span><span lang="EN-IN"><a href="http://www.medicalnewstoday.com/articles/237191.php" title="What is heart disease?"><span style="border: 1pt none windowtext; color: windowtext; padding: 0in; text-decoration: none;">heart
disease</span></a></span><span lang="EN-IN">, kidney
failure, blindness, peripheral nervous system damage, amputations and even
early death.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: .0001pt; margin: 0in; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">"This is completely new and groundbreaking research," </span><strong><span lang="EN-IN">Prof. Tore Bengtsson of Stockholm
University's Department of Molecular Biosciences</span></strong><b><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"> </span></b><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">said.</span><span lang="EN-GB"><o:p></o:p></span></span></div>
<div class="storycopy" style="background: white; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;">
<i><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"><span style="font-family: inherit;">On December 20, 2006, the United Nations (UN) passed a
resolution to designate November 14 as World Diabetes Day. The occasion aimed
to raise awareness of diabetes, its prevention and complications and the care
that people with the condition need. World Diabetes Day was first commemorated
on November 14, 2007, and is observed annually.<o:p></o:p></span></span></i></div>
<div class="storycopy" style="background: white; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;">
<b><span lang="EN-IN"><span style="font-family: inherit;">For
BCC Research market reports on diabetes, visit the following links:<o:p></o:p></span></span></b></div>
<div class="storycopy" style="background: white; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/diabetes-therapeutics-diagnostics-markets-hlc029d.html"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">http://www.bccresearch.com/market-research/healthcare/diabetes-therapeutics-diagnostics-markets-hlc029d.html</span></a></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"><o:p></o:p></span></span></div>
<div class="storycopy" style="background: white; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/insulin-drug-delivery-devices-hlc149a.html"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">http://www.bccresearch.com/market-research/healthcare/insulin-drug-delivery-devices-hlc149a.html</span></a></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"><o:p></o:p></span></span></div>
<div class="storycopy" style="background: white; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/continuous-glucose-monitoring-cgm-technology-markets-hlc102a.html"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">http://www.bccresearch.com/market-research/healthcare/continuous-glucose-monitoring-cgm-technology-markets-hlc102a.html</span></a></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"><o:p></o:p></span></span></div>
<div class="storycopy" style="background: white; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/biotechnology/bioengineered-protein-drugs-report-bio009f.html"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">http://www.bccresearch.com/market-research/biotechnology/bioengineered-protein-drugs-report-bio009f.html</span></a></span><span lang="EN-IN" style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"><o:p></o:p></span></span></div>
<div class="storycopy" style="background: white; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/pharmaceuticals/autoimmune-disease-diagnostics-report-phm160a.html"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">http://www.bccresearch.com/market-research/pharmaceuticals/autoimmune-disease-diagnostics-report-phm160a.html</span></a></span><span lang="EN-IN"><o:p></o:p></span></span></div>
<div style="text-align: left;">
</div>
<div class="storycopy" style="background: white; margin-bottom: .0001pt; margin-bottom: 0in; margin-left: 0in; margin-right: 0in; margin-top: 12.0pt; text-align: justify;">
<span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/eldercare-market-hlc062b.html"><span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;"><span style="font-family: inherit;">http://www.bccresearch.com/market-research/healthcare/eldercare-market-hlc062b.html</span></span></a></span><span lang="EN-IN" style="font-size: 10.0pt;"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-45110570467787792522014-11-11T03:52:00.000-05:002014-11-11T03:52:20.521-05:00The Impact of DNA Vaccines on the Biotechnology Industry<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="background: white; margin-bottom: 0.25in; text-align: justify; vertical-align: baseline;">
<span lang="EN-IN"><span style="font-family: inherit;">Vaccines are considered a standard
preventive treatment in many clinical situations today. They work by inducing
an immune response against an inert pathogen to protect against future
infection. <span style="font-size: small;"><o:p></o:p></span></span></span></div>
<div style="background: white; margin-bottom: 10.2pt; margin-left: 0in; margin-right: 0in; margin-top: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">A new type of vaccine – DNA vaccines – provide an alternative
method to produce immunity in organisms. First developed during the 1990s, DNA vaccines
use genetically engineered DNA to produce an immune response. They work by
causing the body to translate the injected DNA sequences into pathogenic
proteins.<span class="apple-converted-space"> </span>The body then creates
antibodies<span class="apple-converted-space"> </span>specific to the
proteins, which creates immunity without causing infection. This is important
for immune-compromised patients, including those infected by HIV; conventional
vaccines can potentially trigger an actual infection in weakened immune systems.<span class="apple-converted-space"> </span></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.25in; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-IN">Though currently still in the
experimental stages, DNA vaccines have several advantages over conventional
vaccines. Conventional vaccines cover only a small number of diseases, but DNA
vaccines are relatively easy to design for a range of difficult pathogens. </span>DNA
vaccines will target a wide range of diseases, such as cancers and allergies,
as well as infectious diseases. <span lang="EN-IN">Studies over the past decade suggest that DNA
vaccines can be used for immunity against infections and diseases such as
HIV/AIDS and malaria that kill millions worldwide every year. </span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.25in; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-IN">DNA vaccines
are also easier to distribute than traditional vaccines<span class="apple-converted-space"> </span>because they are more stable, avoid
the risk of accidental infection by the pathogen, and require no refrigeration.
</span><span lang="EN-IN">Conventional
vaccines can potentially become inert when stored in improper environments,
while DNA vaccines are less susceptible to damage due to environmental
conditions, such as extreme temperatures or humidity. They can be administered safely
to people who live in areas where regular vaccines are difficult to maintain or
may be compromised due to the lack of proper storage facilities. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.25in; text-align: justify; vertical-align: baseline;">
<span lang="EN-IN"><span style="font-family: inherit;">DNA vaccines, if integrated into
the body appropriately, can produce a sustained immune response, making booster
vaccinations unnecessary. After receiving a single DNA vaccine, an individual
can have lifelong immunity to a disease, decreasing the need (and cost) for
booster shots.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.25in; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-IN">In addition to the general
medical benefits, DNA vaccines can provide a large economic benefit. Due to <a href="https://www.blogger.com/null" name="_GoBack"></a>the decreased restrictions in the production and storage of
DNA vaccines compared to regular vaccines, the cost of producing and maintaining
DNA vaccines is much lower. This can be especially beneficial to people in
developing countries. According to certain case studies, the cost of developing
and manufacturing a successful and beneficial conventional vaccine can range
from </span><span lang="EN-IN"><a href="http://triplehelixblog.com/2011/01/medical-innovation-future-promise-of-dna-vaccines/">$500 million to $1 billion</a></span><span lang="EN-IN">.
Comparatively, the development and manufacturing of a DNA vaccine ranges between
$200 and $300 million.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: 10.2pt; margin-left: 0in; margin-right: 0in; margin-top: 0in; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">Currently there is limited knowledge of the effects of DNA
vaccines on humans, since most tests have been conducted only on lab animals.<span class="apple-converted-space"> </span></span><span lang="EN-IN"><a href="http://www.hcs.harvard.edu/hghr/online/dna-vaccines/">Potential side effects </a></span><span lang="EN-IN">could include chronic inflammation, because
the vaccine continuously stimulates the immune system to produce antibodies.
Other concerns include the possible integration of plasmid DNA into the body’s
host genome, resulting in<span class="apple-converted-space"> </span>mutations, problems
with DNA replication, triggering of autoimmune responses, and activation of
cancer-causing genes.</span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">A
2014 market research report published by BCC Research forecasts the global
market for DNA vaccines will grow from $305.3 million in 2014 to $2.7 billion
in 2019, yielding an impressive compound annual growth rate (CAGR) of 54.8%.
While research tools and animal health applications currently comprise the
commercialized market, human clinical DNA vaccines will make up the vast
majority of this market by 2019.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">In the age of genomics where DNA can be
sequenced and created more quickly, accurately, and cheaper than ever before,
and where safety and handling live pathogens is fraught with risk and
difficulty, </span><span lang="EN-IN"><a href="http://www.bbsrc.com/news/food-security/2012/120717-f-dna-vaccines-and-future-of-disease-control.aspx">further research on DNA vaccines</a></span><span lang="EN-IN"> is surely a worthwhile pursuit when
addressing modern food security, animal health and perhaps even human
healthcare challenges.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For
our market research report on DNA vaccines, visit the following link:<o:p></o:p></span></span></i></div>
<br />
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/biotechnology/dna-vaccines-bio067b.html"><span style="background: white;"><span style="font-family: inherit;">http://www.bccresearch.com/market-research/biotechnology/dna-vaccines-bio067b.html</span></span></a></span><span lang="EN-IN" style="background: white; font-size: 12.0pt; mso-bidi-font-family: "Times New Roman";"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-26168775939542064552014-10-20T09:14:00.000-04:002014-10-20T09:14:31.986-04:00Transforming the Future of Lighting Systems with Led Technology <div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="background: white; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-IN">Although
the origin of Light Emitting Diode or LED technology can be traced back to
1927, it did not enter the commercial arena until much later. This was largely
due to its high production cost; it is, however, rapidly gaining ground in more
recent times. With the increasing demand for greener, more energy-efficient
products, as well as the worldwide environmental strain on energy resources, is
LED technology the answer to our lighting needs? What does the future hold for
LED technology and does it have what it takes to overpower the traditional
light bulb, which was perhaps the most life</span><span lang="EN-IN">‐</span><span lang="EN-IN">changing invention in human
history?</span><span lang="EN-IN"><o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; text-align: justify; vertical-align: baseline;">
<span lang="EN-IN"><span style="font-family: inherit;">LED
lights are likely the most environmentally friendly lighting options available
in the current scenario. So what makes it the leading choice in industrial,
architectural, and horticultural applications around the world? LEDs last as
much as 20 times longer than other lighting sources, and therefore don’t need
to be replaced as often. This reduces the impact of manufacturing, packaging,
and shipping. LEDs are also designed to provide more than a decade of near
maintenance-free service. Less servicing also reduces environmental impact.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-IN">Additionally, LEDs consume much less
energy than incandescent and high-intensity discharge (HID) lights. LED
lights use only 2–17 watts of electricity, which is 25%–80% less energy than
standard lighting systems. And while compact fluorescent lights are also
energy-efficient, LEDs burn even less energy.</span><span lang="EN-IN" style="color: dimgrey;"> </span><span lang="EN-IN">LEDs contain no mercury, unlike
their HID counterparts, whose mercury-laden remnants can seep into the water
supply and adversely affect sea life, and those who consume it. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify; vertical-align: baseline;">
<br /></div>
<div class="MsoNormal" style="background: white; margin-bottom: 0.0001pt; text-align: justify; vertical-align: baseline;">
<span style="font-family: inherit;"><span lang="EN-IN">According to the </span><span lang="EN-IN"><a href="http://www.illumitex.com/environmental-benefits-using-led-lights/">U.S. Department of Energy</a></span><span lang="EN-IN">, “Widespread use of LED lighting
has the greatest potential impact on energy savings in the United States. By
2027, widespread use of LEDs could save about 348 terawatt hours (compared to
no LED use) of electricity: This is the equivalent annual electrical output of
44 large electric power plants (1000 megawatts each), and a total savings of
more than $30 billion at today’s electricity prices.”<o:p></o:p></span></span></div>
<div style="background: white; margin-top: 0in; mso-line-height-alt: 9.35pt;">
<br /></div>
<div style="background: white; margin-top: 0in; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">The electrical maintenance required for lighting
systems in </span><span lang="EN-IN"><a href="http://www.triplepundit.com/2013/10/led-lighting-public-buildings/">public buildings</a></span><span lang="EN-IN"> that receive harsh and prolonged use, sometimes 24
hours a day, 365 days of the year, is overwhelming. <span style="color: #111111;">In
public building management, time is money, and because changing LED fixtures
happens far less often than traditional lighting, public building management
will have to spend less time on the ladder changing bulbs. LED lighting
contributes to energy savings and sustainability by improving working
conditions through deliberately directed light and by reducing the energy
needed to power lighting fixtures.</span><o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 0in; mso-line-height-alt: 9.8pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">A groundbreaking advancement in this area
came to the forefront when Isamu Akasaki, Professor at Meijo University,
Hiroshi Amano, Professor at Nagoya University, and Shuki Nakahmura, a
Japanese-born Professor currently at the University of California, Santa Barbara
won the Nobel Prize in Physics earlier this month for inventing the world’s
first </span><span lang="EN-IN"><a href="http://www.iflscience.com/physics/nobel-prize-physics-awarded-scientists-who-invented-blue-led">blue light-emitting diodes</a></span><span lang="EN-IN"> (LEDs). <o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">While red and green LEDs had been around for some time, the elusive
blue LED represented a long-standing challenge for researchers in both academia
and industry. Without this critical last piece, scientists were unable to
produce white light from LEDs, as all three colors needed to be mixed together
for this to happen.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 0in; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">The white LED lamps that resulted from this invention emit very bright
white light and are superior in terms of energy efficiency and lifespan when
compared with incandescent and fluorescent bulbs. LEDs can last some
100,000 hours, whereas incandescent bulbs typically last only about 1,000.
“With 20% of the world’s electricity used for lighting, it’s been calculated
that optimal use of LED lighting could reduce this to 4%,”<span class="apple-converted-space"> </span></span><span lang="EN-IN"><a href="http://www.bbc.co.uk/news/science-environment-29518521">said Dr. Frances Saunders</a></span><span lang="EN-IN" style="color: #424242;">, </span><span lang="EN-IN">President of the Institute of Physics. “This is
physics research that is having a direct impact on the grandest of scales,
helping protect our environment, as well as turning up in our everyday
electronic gadgets.”<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 0in; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">What’s more, these LED lamps have the potential to improve the quality
of life for more than<span style="color: #424242;"> </span></span><span lang="EN-IN"><a href="http://phys.org/news/2014-10-japanese-american-nobel-prize-physics.html">1.5 billion people</a></span><span class="apple-converted-space"><span lang="EN-IN" style="color: #424242;"> </span></span><span lang="EN-IN">in
the world that do not have access to electricity grids. Since LEDs require very
little energy input, they can run on cheap local solar power. <o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 0in; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://qz.com/146761/forget-led-bulbs-the-future-of-interior-lighting-is-lasers/"><span style="color: windowtext; text-decoration: none;">Steven DenBaars</span></a>,</span><span lang="EN-IN"> </span><span lang="EN-IN"><a href="http://www.materials.ucsb.edu/LINKS/PROFdenbaars/hp.denbaars.html"><span style="color: windowtext; text-decoration: none;">a research scientist at UC Santa Barbara</span></a>, has been working on
LED lights for 20 years. In his laboratory, he is already onto the next big
thing: Replacing a substantial portion of indoor lights, and the archaic bulb
and socket infrastructure on which they depend, with lasers.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">According to DenBaars, the working of lasers is very similar to an LED
lightbulb. “It’s the same materials, but you put two mirrors on either side of
the LED and it breaks into a laser. Once you get reflection back and forth, you
get an amplification effect, and it goes from regular emission to stimulated
emission.”<o:p></o:p></span></span></div>
<div style="background: white; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Simply replacing the light emitting diodes in a
typical LED bulb with a laser diode wouldn’t work. This hypothetical laser
light bulb would catch on fire from all the waste heat it would generate, not
to mention an ungodly amount of light, more than enough to blind anyone who
looked at it. Rather, DenBaars imagines using just a handful of tiny but
powerful lasers, and then redirecting their light into fiber-optic cables and
other types of light-transmitting plastic that could take that light and evenly
distribute it into a warm, diffuse glow.<o:p></o:p></span></span></div>
<div style="background: white; text-align: justify;">
<br /></div>
<div style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">BMW’s “hybrid supercar,” the i8, uses headlights that are the latest
example of laser-based lighting technology. Like all lasers re-appropriated for
conventional illumination, blue laser diodes were aimed at a phosphor that
transforms the blue laser light into more diffused white light. The result is
headlights with such a long working life that they could “easily outlive the
automobile” in which they’re installed, notes IEEE Spectrum.<o:p></o:p></span></span></div>
<div style="background: white; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Laser lights could solve the problem of how to bridge
the gap between traditional light sockets and more radical configurations of
new lighting technologies. With just a few point sources of laser light
installed in a building, their illumination can be redirected throughout a
structure via plastic fiber-optic cables that could run along ceilings and
around corners, just as the cable company runs its wires into buildings and
through rooms without having to tear holes in walls or interface with the
electrical system of a building. “Rather than route the electricity to the bulb
you can route the light to the sources. LEDs let you do that too, but lasers
would take it a couple steps further,” says DenBaars.<o:p></o:p></span></span></div>
<div style="background: white; margin-bottom: 12.0pt; margin-left: 0in; margin-right: 0in; margin-top: 0in; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">LEDs are helping change the way we light up our world, facilitating the
development of environmentally friendly, energy-efficient light sources that
offer a dramatic improvement from the incandescent bulbs pioneered at the
beginning of the 20th century.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="background: white; line-height: 13.5pt; margin-bottom: .0001pt; margin-bottom: 0in; vertical-align: baseline;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For our
relevant BCC Research report on LED, visit the following link:<o:p></o:p></span></span></i></div>
<div class="MsoNormal" style="background: white; text-align: justify; vertical-align: baseline;">
</div>
<div class="MsoNormal" style="background: white; line-height: 13.5pt; margin-bottom: .0001pt; margin-bottom: 0in; vertical-align: baseline;">
<span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/semiconductor-manufacturing/light-emitting-diodes-led-lighting-applications-smc018d.html"><span style="font-family: inherit;">http://www.bccresearch.com/market-research/semiconductor-manufacturing/light-emitting-diodes-led-lighting-applications-smc018d.html</span></a></span><span lang="EN-IN" style="color: dimgrey; font-family: "Times New Roman","serif"; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: EN-IN;"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-67406816377284493992014-10-13T03:18:00.000-04:002014-10-13T03:18:24.197-04:00Minding Our Brain’s Business: Unravelling The Neuroscience Of The Human Brain<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">For
centuries, the mysteries of grey matter have baffled scientists and researchers
alike. How can humans manage to store countless moments, past and present, in
one single organ? How can animals map their path back and forth? How do we
figure out a shortcut to work when there's a big traffic jam? How do we recall
where we parked our car? So on and so forth.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">The brain, as it turns
out, has a </span><span lang="EN-IN"><a href="http://www.lasvegassun.com/news/2014/oct/06/nobel-prize-for-work-on-brains-navigation-system/">GPS-like function</a></span><span lang="EN-IN"> that enables people
to produce mental maps and navigate the world — a discovery for which husband-and-wife
scientists Edvard Moser and May-Britt Moser of Norway, and New York-born
researcher John O'Keefe were recently honored for breakthroughs in experiments
on rats that could help pave the way for a better understanding of human
diseases such as Alzheimer's. This solves the problem of how the brain creates
a map of the space surrounding us and how we navigate our way through a complex
environment. In other words, it reveals brain's internal positioning system and
gives clues to how strokes and Alzheimer's affect the brain.<o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">"We
can actually begin to investigate what goes wrong" in Alzheimer's, said
O'Keefe. "The findings might also help scientists design tests that can
pick up the very earliest signs of the mind-robbing disease, whose victims lose
their spatial memory and get easily lost," he added.<o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">It was
in London in 1971 where O'Keefe, conducting his research on rats, discovered
the first component of the brain's positioning system. O'Keefe, now director at
the center in neural circuits and behavior at University College London, found
that a type of nerve cell in a brain region called the hippocampus was always
activated when a rat was in a certain place in a room. Other nerve cells were
activated when the rat was in other positions. O'Keefe, thereafter, concluded
that these "place cells" were building up a map, not just registering
visual input.<o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">"I
made the initial discovery over 40 years ago. It was met then with a lot of scepticism,"
the 74-year-old O'Keefe said. "And then slowly over years, the evidence
accumulated. And I think it's a sign of recognition not only for myself and the
work I did, but for the way in which the field has bloomed."<o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">What is
vital, however, is that the knowledge about the brain's positioning system can
also help understand what causes loss of spatial awareness in stroke patients
or those with brain diseases like dementia, of which Alzheimer's is the most
common form and which affects </span><span lang="EN-IN"><a href="http://www.msn.com/en-za/news/featured/nobel-prize-for-discovery-of-brains-internal-gps/ar-BB7QvWV">44 million people worldwide</a></span><span lang="EN-IN">.<o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">In
1996, Edvard Moser and May-Britt Moser, now based in scientific institutes in
the Norwegian town of Trondheim, worked with O'Keefe to learn how to record the
activity of cells in the hippocampus. In 2005, they identified another type of
nerve cell in the entorhinal cortex region in the brains of rats that functions
as a navigation system. These so-called "grid cells," they
discovered, are constantly working to create a map of the outside world and are
responsible for animals' knowing where they are, where they have been, and
where they are going.<o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">The
Nobel Assembly said the laureates' discoveries marked a shift in scientists'
understanding of how specialized cells work together to perform complex
cognitive tasks. They have also opened new avenues for understanding cognitive
functions such as memory, thinking, and planning. <o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">The
finding, a fundamental piece of research, explains how the brain works but does
not have immediate implications for new medicines, since it does not set out a
mechanism of action.<o:p></o:p></span></span></div>
<div style="margin-bottom: .0001pt; margin-bottom: 0in; text-align: justify;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For
our relevant BCC Research reports on Alzheimer’s, visit the following links:<o:p></o:p></span></span></i></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/pharmaceuticals/neurostimulation-markets-phm149a.html"><span lang="EN-US">http://www.bccresearch.com/market-research/pharmaceuticals/neurostimulation-markets-phm149a.html</span></a></span><span style="color: #1f497d; mso-ansi-language: EN-US;"><o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: left;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/pharmaceuticals/alzheimers-disease-phm062b.html"><span lang="EN-US">http://www.bccresearch.com/market-research/pharmaceuticals/alzheimers-disease-phm062b.html</span></a></span><span style="color: #1f497d; mso-ansi-language: EN-US;"><o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: left;">
<br /></div>
<div style="text-align: left;">
</div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: left;">
<span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/pharmaceuticals/dementia-movement-disorders-treatments-global-markets-phm117a.html"><span lang="EN-US"><span style="font-family: inherit;">http://www.bccresearch.com/market-research/pharmaceuticals/dementia-movement-disorders-treatments-global-markets-phm117a.html</span></span></a></span><span style="color: #1f497d; mso-ansi-language: EN-US;"><o:p></o:p></span></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-4653549558208687692014-10-10T03:52:00.000-04:002014-10-10T03:52:29.553-04:00The Changing Face of the Healthcare Industry with Mhealth Technologies<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: justify;">
<span lang="EN-IN" style="font-size: 11.0pt;"><span style="font-family: inherit;">The
health industry is increasingly responding to the rising popularity and
availability of technological innovations, such as tablets and smartphones. The
use of connected devices to collect patient data, monitor ongoing conditions,
access health information, and communicate with providers, patients, and peers
is a trend that is spreading like wildfire. Health applications have the
potential to be adapted and used by healthcare professionals and consumers,
helping to revolutionize the sector and reflect the digital age we live in.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Mobile Health (mHealth)
can provide cost-effective solutions within the global healthcare environment,
which faces budget constraints, an increasing prevalence of chronic conditions,
and a limited healthcare workforce. mHealth is the use of mobile and wireless
technologies to support healthcare systems and achieve healthcare
objectives. After several successful
global trials, several mHealth services have entered the commercialization
phase and many mobile applications have been launched, stimulating partnerships
with software developers, mobile operators, governmental and non-governmental
organizations, and leading healthcare players. <o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">Over the next decade
innovations within the mHealth market will be driven by evolution of smartphone
technologies, improvements in wireless coverage, and remote treatment and
monitoring of prevalent chronic diseases. According to a BCC Research report, the
global mHealth market reached nearly $1.5 billion in 2012 and $2.4 billion in
2013. It is expected to reach $21.5 billion in 2018 with a compound annual
growth rate (CAGR) of 54.9% over the five-year period from 2013 to 2018.<o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="font-size: 11.0pt;">For
healthcare professionals, mobile or tablet apps also have enormous potential
for </span><span lang="EN-IN"><a href="http://www.theguardian.com/healthcare-network/2012/aug/21/apps-healthcare-tablets-mobile-smartphones"><span style="font-size: 11.0pt;">training and professional development</span></a></span><span lang="EN-IN" style="font-size: 11.0pt;">. Connectivity is built in, facilitating a
blended learning platform with easily updatable information, in an accessible
format. This allows for a truly flexible and enjoyable teaching and learning
experience, ideal for both professionals and students, with information available
anytime, anywhere.<o:p></o:p></span></span></div>
<div style="text-align: justify;">
<span lang="EN-IN" style="font-size: 11.0pt;"><span style="font-family: inherit;">Not
only do health training and development apps provide more dynamic training
tools, but they can also bring huge cost savings. Apps are inexpensive to
produce and update, especially when compared to other training tools. Tablets and
smartphones are readily available and the technology is relatively low cost
when compared to other health technologies and professional training tools.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN" style="background: white;">Apple’s
new software, </span><span lang="EN-IN"><a href="http://www.forbes.com/sites/dandiamond/2014/09/26/apples-healthkit-finally-arrives-after-bugs-botches-and-boatloads-of-apple-hype/"><span style="background: white;">HealthKit</span></a>,</span><span lang="EN-IN" style="background: white;"> is
designed to collect data from various health and fitness apps, making that data
easily available to Apple users through the company’s new Health app. HealthKit
is being developed to<span class="apple-converted-space"> </span><span style="border: none windowtext 1.0pt; mso-border-alt: none windowtext 0in; padding: 0in;">send data directly</span><span class="apple-converted-space"> </span>into
hospital and doctors' charts, too.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span lang="EN-IN" style="background: white;"><span style="font-family: inherit;">Craig
Federighi, Senior Vice President at Apple, at a conference held earlier this
year, said, “Developers have created a vast array of healthcare devices and
accompanying applications, everything from monitoring your activity level, to
your heart rate, to your weight, and chronic medical conditions like high blood
pressure and diabetes. ... [But] you can’t get a single comprehensive picture
of your health situation. But now you can, with HealthKit.”<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">Mobile phone carriers
such as </span><span lang="EN-IN"><a href="http://www.verizonwireless.com/">Verizon</a></span><span lang="EN-IN"> and </span><span lang="EN-IN"><a href="http://www.sprint.com/mysprint/pages/sl/global/index.jsp?context=CP&INTNAV=TSC:IHP:ExpWC:CP:053014">Sprint</a></span><span lang="EN-IN"> are also using their
vast and trusted networks to bring </span><span lang="EN-IN"><a href="http://ehrintelligence.com/2013/12/19/five-key-trends-for-mhealth-and-telehealth-in-2014/">mobile patient engagement</a></span><span lang="EN-IN"> and data to the forefront.
“[Verizon’s] Converged Health Management is a perfect example of how we are
using our unique combination of assets like our 4G LTE wireless network and
cloud infrastructure to deliver an innovative, cost-effective and game-changing
solution to the marketplace,” said John Stratton, President of Verizon Enterprise
Solutions.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="text-align: justify;">
<i><span lang="EN-IN"><span style="font-family: inherit;">For
relevant BCC Research reports on telemedicine technologies, visit the following
links:<o:p></o:p></span></span></i></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/healthcare/mobile-health-hlc162a.html">http://www.bccresearch.com/market-research/healthcare/mobile-health-hlc162a.html</a></span><span lang="EN-IN"><o:p></o:p></span></span></div>
<span lang="EN-IN" style="font-size: 11pt; line-height: 115%;"><a href="http://www.bccresearch.com/market-research/healthcare/telemedicine-technologies-report-hlc014g.html"><span style="font-family: inherit;">http://www.bccresearch.com/market-research/healthcare/telemedicine-technologies-report-hlc014g.html</span></a></span></div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-5885086782000467172014-10-08T03:22:00.000-04:002014-10-08T03:23:27.140-04:00MISSION SAVE EARTH: EMERGING TRENDS IN ENVIRONMENTAL SENSING AND MONITORING TECHNOLOGIES<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;">Environmental field
monitoring technologies have advanced rapidly in the last decade, concurrent
with advances in digital technology, computational power and Internet-enabled
communications. Environmental sensors have become much smaller, faster and
often less expensive. Advances in air-sensing technologies, in particular, now
enable rapid retrieval of time-critical pollution data on a large scale. Fast,
low-cost sensors afford the possible networking of multiple units within a
sensor grid network so that even street-level monitoring can be achieved.</span></div>
<div class="MsoNormal" style="text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">Several governments across the
globe are playing an active role in funding and encouraging environmental
monitoring programs, thereby keeping the growth in the global market buoyant.</span><span lang="EN-IN"> In the U.S. market
alone, some $250 billion of economic output stems from all pollution control
and monitoring activities each year. Among the faster-growing segments of this business
are the markets for sophisticated sensors; monitoring equipment; large-scale
networks, such as satellite, GPS and remote sensing; associated networking
equipment and ancillaries; and a large slate of new technologies. Globally, the
markets for environmental sensors and the related subsegments account for
approximately $13 billion of economic activity at present, with a projected
average annual growth of 5.9% through 2019, according to a BCC Research report.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">Among
the key trends in the environmental sensors industry are miniaturization down
to the nano scale, continuous and/or real-time sensing capabilities, wireless
networked operation, rapid processing, and increased sensitivity or
flexibility. Dominant trends in the sensors business include the development of
more large-scale monitoring systems, such as remote sensing and satellite-based
large-area sensors. Private companies are now getting into the environmental
monitoring satellite business. Mobile environmental sensing systems are being
increasingly tested and proposed for urban areas. Such systems are used to
identify and monitor urban air pollution events, and correlations can be made
between resulting data and levels of local transport or industrial activity. A </span><span lang="EN-IN"><a href="http://www.futuregov.asia/articles/2014/sep/10/singapore-track-residents-waste-disposal-new-high-/">new public housing estate in
Singapore</a></span><span lang="EN-IN">,
to be launched in 2015 in the Punggol Northshore district, will install sensors
to monitor residents’ waste disposal. The housing authority will then analyze
the data collected to deploy resources for waste collection. The district will
also feature other smart technologies such as intelligent car parking areas and
smart lighting.<o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span style="font-family: inherit;"><span lang="EN-IN">The
United States 2009 Economic Recovery Act provided additional hundreds of
millions of dollars for research on environmental monitoring and sensors to U.S.
entities such as the EPA, the DOE, NASA and certain government labs. Advancements
have been made in networking from space; with additional satellites, networked
coverage of the globe’s surface is becoming ever more comprehensive. <span class="hei14">China successfully launched the </span></span><span lang="EN-IN"><a href="http://news.xinhuanet.com/english/china/2014-09/08/c_133627945.htm">Yaogan-21</a></span><span class="hei14"><span lang="EN-IN">
remote sensing satellite from Taiyuan Satellite Launch Center in September 2014.
</span></span><strong><span lang="EN-IN">Yaogan-21 will be used for scientific
experiments, natural resource surveys, estimation of crop yield and disaster
relief.</span></strong><span lang="EN-IN"><o:p></o:p></span></span></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<br /></div>
<div class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;">
<span lang="EN-IN"><span style="font-family: inherit;">In
light of the now-numerous international reports on climate change that confirm
man’s considerable impact on the environment, scientists agree that more
sophisticated monitoring programs are urgently needed to detect ecological
changes before they become irreversible. The surging need to monitor emissions
continues to fuel the need to develop more sensitive and cost-effective
environmental sensors. Nanotechnology and micro-electromechanical technology
improvements in sensor development, design, and production, are expected to
benefit the market. Nanotechnology enables sensors to be selective in the
detection of multiple analytes and enables monitoring their presence in real
time. The sensors business is a very dynamic area of the economy, and thus it
is a sector with huge profit-making potential if one can correctly identify
future opportunities in environmental sensing.<o:p></o:p></span></span></div>
<div style="text-align: justify;">
<i><span lang="EN-IN" style="font-size: 11.0pt;"><span style="font-family: inherit;">For our relevant BCC Research report on
environmental sensing and monitoring technologies, visit the following link:<o:p></o:p></span></span></i></div>
<br />
<span lang="EN-IN"><a href="http://www.bccresearch.com/market-research/instrumentation-and-sensors/environmental-sensor-markets-ias030c.html"><span style="font-size: 11.0pt;"><span style="font-family: inherit;">http://www.bccresearch.com/market-research/instrumentation-and-sensors/environmental-sensor-markets-ias030c.html</span></span></a></span><span lang="EN-IN" style="font-size: 11.0pt;"><o:p></o:p></span></div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-68318950623520258222014-09-23T03:56:00.002-04:002014-09-23T03:57:31.045-04:00To Preserve or Not To Preserve: Future of Stem Cell Research<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="MsoNormal">
<span style="font-size: 11pt;"><span style="font-family: inherit;">The
banking or preservation of stem cells such as from umbilical cord blood or bone
marrow has been increasing, as the potential for using stem cells in clinical
applications continues to fuel speculation and expectations. <span style="background-attachment: initial; background-clip: initial; background-color: white; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">Researchers have been steadily exploring various ways
to use stem cells at the optimum level, what types to use and how to deliver
them to the body — findings that are not only transformational, but also progressive
and pragmatic. <o:p></o:p></span></span></span></div>
<div class="MsoNormal" style="background: white; mso-hyphenate: auto;">
<span style="font-family: inherit; font-size: 11pt;">Preliminary and promising
research through </span><a href="http://www.whattoexpect.com/pregnancy/cord-blood/cord-blood-research.aspx" style="font-family: inherit;"><span style="font-size: 11pt;">clinical and
experimental trials</span></a><span style="font-family: inherit; font-size: 11pt;">
suggests that stem cells may be able to treat autoimmune diseases such as type
1 diabetes, Parkinson’s disease, brain and spinal-cord injuries, cardiovascular
disease, liver disease, kidney disease, and breast cancer, among other
illnesses. Either donated or stored privately, cord-blood banking is proving to
be a rich source of life-saving treatment — now and in the future, as the
possibilities of cord blood continue to expand.</span></div>
<div class="MsoNormal">
<span style="font-family: inherit;"><span style="font-size: 11pt;">“Initial
studies suggest that stem cell therapy can be delivered safely,” said<span class="apple-converted-space"> </span>Dr. Ellen Feigal, Senior Vice President
of research and development at the </span><span style="font-size: 11pt;">California
Institute of Regenerative Medicine</span>,<span style="font-size: 11pt;"> which was awarded more than $2 billion
toward stem cell research since 2006 and is enrolling patients in 10 clinical
trials this year. <span style="background: white;">In addition to continuing
safety research, Dr. Feigel added, “Now what we want to know is</span> <span style="background: white;">will it work, and will it be better than what’s
already out there?”</span></span></span></div>
<div class="MsoNormal">
<span style="font-family: inherit;"><span style="font-size: 11pt;">On
the other hand, Dr. Charles Murry, Co-director of the </span><a href="http://depts.washington.edu/iscrm/"><span style="font-size: 11pt;">Institute for Stem Cell and Regenerative
Medicine</span></a><span style="font-size: 11pt;">
at the University of Washington<span style="background: white;">, believes that
it is important to note that very few therapies beyond bone marrow transplants
have been shown to be effective. Websites, newspapers and magazines advertising
stem cell therapies leave the impression among the masses that such treatments
are ready to use and that “the only problem is the evil physicians and
government, who want to separate people from lifesaving therapies,” he said.</span></span></span></div>
<div class="MsoNormal">
<span style="font-family: inherit;"><span style="background: white; font-size: 11pt;">Scientists are now exploring direct therapies in new and
innovative ways, such as reproducing and studying diseases in a dish using
cells created from patients with specific ailments.<span style="color: red;"> </span></span><span style="font-size: 11pt;">Kevin Eggan, associated
with the </span><span style="font-size: 11pt;">Harvard Stem Cell Institute</span><span style="font-size: 11pt;">, is using this
technique to study<span class="apple-converted-space"> </span></span><span style="font-size: 11pt;">amyotrophic
lateral sclerosis</span><span style="font-size: 11pt;">,
or Lou Gehrig’s disease. He began his work five years ago when he took skin
cells from two women dying from the same genetic form of ALS. He turned these
skin cells into stem cells and then into nerve cells, and discovered an
electrical problem—the cells weren’t signaling to one another properly, which he
theorized was probably causing the neural degeneration that characterizes ALS.</span></span></div>
<div class="MsoNormal">
<span style="font-size: 11pt;"><span style="font-family: inherit;">After
replicating these nerve cells multiple times and testing various drug compounds
to see which would correct the electrical signaling problem, he found a
candidate drug — an existing medication approved for epilepsy — that will be
tested in ALS patients as soon as the end of this year.</span></span></div>
<div class="MsoNormal">
<span style="font-size: 11pt;"><span style="font-family: inherit;">Increasingly,
though, companies are competing with medical institutions offering stem cell
harvesting and preservation services. Parents seeking to preserve stem cells
for their children are turning to the harvesting and preservation of umbilical
cord blood as a source of stem cells. Further, the harvesting of stem cells
from adults for their future use in cellular therapeutic applications and/or
tissue engineering needs has emerged as a growing facet of the stem cell
market. Even further, companies are emerging that offer patients the
opportunity to clone their own line of embryonic stem cells.</span></span></div>
<div class="MsoNormal" style="background: white; margin-bottom: 12.0pt; mso-hyphenate: auto;">
<span style="font-size: 11pt;"><span style="font-family: inherit;">The
real medical challenge is, however, to uncover which type of cell therapy best addresses
each particular medical condition. <span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial;">With numerous
experiments and huge amounts of money involved, scientists and researchers have
yet to come up with the most cost-effective ways to deliver stem cells. <o:p></o:p></span></span></span></div>
<div class="MsoNormal">
<i><span style="font-size: 11pt;"><span style="font-family: inherit;">For our relevant
BCC Research stem cell report, visit the following link:<o:p></o:p></span></span></i></div>
<div class="MsoNormal">
<br /></div>
<div class="MsoNormal">
<span style="font-family: inherit;"><a href="http://www.bccresearch.com/market-research/biotechnology/stem-cells-bio035e.html"><span style="font-size: 11pt;">http://www.bccresearch.com/market-research/biotechnology/stem-cells-bio035e.html</span></a><u><span style="color: blue; font-size: 11pt;"><o:p></o:p></span></u></span></div>
<br />
<div class="MsoNormal">
<br /></div>
</div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0tag:blogger.com,1999:blog-3372750796246085384.post-59221390061893437482014-09-19T04:38:00.001-04:002014-09-19T04:45:44.806-04:00THE BIG BANG THEORY OF WEARABLE TECHNOLOGY<div dir="ltr" style="text-align: left;" trbidi="on">
The impending explosion of the wearable computing market is one of the most interesting and highly anticipated developments taking place in the high-tech industry. The $3 billion wearable consumer market is intrinsically linked with the $240+ billion smartphone market. The key market driver for wearable computing is the soaring global popularity of smartphones from manufacturers including Apple, Samsung Electronics, LG Electronics, HTC, Blackberry, Nokia and Microsoft. <br /><br />The burgeoning field of <a href="http://blogs.cisco.com/ioe/the-future-of-wearable-technology-smaller-cheaper-faster-and-truly-personal-computing/" rel="nofollow" target="_blank">wearable technology</a> is hitting the mainstream and one of the highlights of high-tech wearable devices is that they are getting smaller, faster, cheaper, and more powerful with every new product. The computing power of an Electronic Numerical Integrator And Computer or ENIAC a decade ago can now be easily fitted inside a chip in a musical greeting card. Similarly, the smartphones today are more powerful than the PCs used, say, five years ago. Now, all the capabilities of a smartphone like making calls, taking pictures, connecting to the internet, video chats, and so on, are being condensed into smartwatches—practically everything a phone or a tablet can do.<br /><br />If the growing trend in the <a href="http://www.forbes.com/sites/salesforce/2014/09/07/wearable-tech-business/" rel="nofollow" target="_blank">wearable computing industry</a> is to be believed, the time may soon come when phones and tablets are a thing of the past. Google Glass is a perfect example. The product is still under development, but if everything goes as planned, consumers will soon have no need for their standard smartphone. Google Glass will be able to easily respond to verbal commands, augmented by the occasional manual interaction via controls located directly on the frame. There has even been talk about eventually including a laser-projected virtual keyboard for those times when voice just isn’t enough. With the ability to access countless sources of information in seconds and then relay them to a miniature screen situated in the upper corner of the wearer’s vision field, Google Glass makes 4G internet connectivity features seem archaic. <br /><br />Motorola recently entered the ring with its Moto 360 smartwatch, which is primarily voice operated and can easily display messages and reminders on command. The result is a small, stylish accessory that serves as an assistant, calendar, and phone all at once and completely replaces the smartphone.<br /><br />However, Apple's stated entry into the <a href="http://www.newser.com/article/c6775bb69c084d10b79d26842abc30df/will-the-apple-watch-be-a-game-changer-for-wearable-technology.html" rel="nofollow" target="_blank">smartwatch arena</a> last week with a device that won't go on sale until early 2015 raises questions: Can the company work its magic as it has in the past and convince people that they really need a smartwatch —or will this time be different? Referring to its much awaited product of the year, iWatch, Apple CEO Tim Cook said in a press release, “Apple introduced the world to several category-defining products, the Mac, iPod, iPhone and iPad. And once again Apple is poised to captivate the world with a revolutionary product that can enrich people's lives. It's the most personal product we've ever made.”<br /><br />In fact, the “wearable category” covers almost everything from Fitbit's $99 Flex fitness tracker and Nike's $99 Fuelband fitness monitors to Samsung's $199 Galaxy Gear smartwatch. In January 2014, Washington-based Innovega revealed its latest effort in introducing a wearable computer in the form of contact lenses at the CES trade show held in Las Vegas, USA—<a href="http://www.engineering.com/DesignerEdge/DesignerEdgeArticles/ArticleID/6915/The-Future-of-Wearable-Computing-is-Coming-Into-Focus.aspx" rel="nofollow" target="_blank">iOptik</a>. Synchronizing its operations with the human eye, the iOptik uses its lenses to project an image of apps and information through the wearer’s pupil and onto the back of the retina. The lenses superimpose one upon the other to produce an image overlaid with information. The product is yet to be given approval by the US Food and Drug Administration (FDA); however, the company plans to schedule further operations later this year or early next year.<br /><br />Wearable computing concept is evolving to be even more personal, and not just for the benefit of the wearer. Expectant mothers, in the near future, will wear electronic “tattoos”—smartsensing stickers that will monitor fetal heart rate and brain waves, detect early signs of labor, and even notify the doctor directly when it’s time to go to the hospital.<br /><br />Wearable computing devices have potential benefits for any situation where information or communication is desired, and the use of a hands-free interface is considered beneficial or essential. In addition to consumer products, many industry-specific applications in markets such as defense, healthcare, manufacturing and mining are also emerging. <br /><br />The growth of the consumer market for wearables largely depends on how rapidly existing smartphone users will adopt wearable accessories and alternative devices. With new and improved innovation hitting the global market every day, only time will reveal whether wearables will ultimately replace smartphone technology in many consumer environments. <br /><br /><b>For our relevant report on wearable technology, visit the following link:</b><br /><a href="http://www.bccresearch.com/market-research/information-technology/wearable-computing-ift107a.html">http://www.bccresearch.com/market-research/information-technology/wearable-computing-ift107a.html</a></div>
BCC Researchhttp://www.blogger.com/profile/15233042904030870993noreply@blogger.com0